<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="review-article" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2026.1666138</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Functional analysis of distinct factors linked to the development of latent to active tuberculosis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Sundaram</surname><given-names>Karthikeyan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2683813/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Prabhu</surname><given-names>Venkataraman</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>*</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1835078/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>Department of Herbal Pharmacology and Environmental Sustainability, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education</institution>, <city>Kelambakkam</city>, <state>Chennai, Tamilnadu</state>, <country country="in">India</country></aff>
<aff id="aff2"><label>2</label><institution>Division of Medical Research, SRM Medical College Hospital and Research Centre</institution>, <city>Kattankulathur</city>, <state>Chennai, Tamilnadu</state>, <country country="in">India</country></aff>
<author-notes>
<corresp id="c001"><label>*</label>Correspondence: Venkataraman Prabhu, <email xlink:href="mailto:venkatap@srmist.edu.in">venkatap@srmist.edu.in</email></corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-01-28">
<day>28</day>
<month>01</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="corrected" iso-8601-date="2026-03-10">
<day>10</day>
<month>03</month>
<year>2026</year></pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>16</volume>
<elocation-id>1666138</elocation-id>
<history>
<date date-type="received">
<day>15</day>
<month>07</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>01</month>
<year>2026</year>
</date>
<date date-type="rev-recd">
<day>07</day>
<month>11</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2026 Sundaram and Prabhu.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Sundaram and Prabhu</copyright-holder>
<license>
<ali:license_ref start_date="2026-01-28">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Tuberculosis is an infectious disease spread through airborne droplet nuclei. <italic>Mycobacterium tuberculosis</italic> is the etiological agent of this infection. Mycobacteria can cause active tuberculosis or asymptomatic latent infection due to its complex biology and host immunological responses. The genes of mycobacteria can change alveolar macrophages and boost their resistance to autophagosome-lysosome fusion. However, only 5%&#x2013;10% of infected individuals progress to the active form. In this context, multiple factors are associated with the progression of the disease. Thus, the review aims to analyze the essential factors linked to the progression from latent to active tuberculosis. The mycobacterium genome closely links these factors. Importantly, mycobacteria possess numerous genes to act as a self-defense mechanism against autophagosome-lysosome fusion. The <italic>PE_PGRS</italic> proteins play an essential role in this mechanism. This protein, when combined with <italic>Rab1A</italic>, helps activate <italic>Rab1A</italic> GTP, hence boosting <italic>mTOR</italic> and preventing autophagy. The presence of certain miRNAs, probably <italic>miR-142-3p</italic>, reduced the development of the phagosome in macrophages; <italic>circRNA</italic>-<italic>0003528</italic> helped change macrophages related to Mycobacterium by increasing CTLA4 and decreasing <italic>miR-224-5p, miR-324-5p</italic>, and <italic>miR-488-5p</italic>. Single-cell technologies like RNA sequencing can properly examine adaptive immune cell types in healthy people and patients, including CD4+, CD8+ T, and B cells. Deficiency of CD4+ T cells increases the risk of TB and can transform an infection into active tuberculosis. Therefore, research on autophagy-regulated genes and T-cell-mediated immune response, along with transcriptome analyses will determine the pathogenesis of tuberculosis, differentiate between active and latent TB, and facilitate the critical role of diagnostic biomarkers.</p>
</abstract>
<kwd-group>
<kwd>tuberculosis</kwd>
<kwd>active tuberculosis</kwd>
<kwd>latent tuberculosis</kwd>
<kwd>autophagy</kwd>
<kwd>immune response</kwd>
</kwd-group>
<funding-group>
<funding-statement>The author(s) declared that financial support was received for this work and/or its publication. The authors gratefully acknowledge the financial support provided by SRM Medical College Hospital and Research Centre, Faculty of Medicine and Health Sciences, SRMIST, Kattankulathur, Tamil Nadu, India.</funding-statement>
</funding-group>
<counts>
<fig-count count="1"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="95"/>
<page-count count="10"/>
<word-count count="5209"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Bacteria and Host</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>The infectious disease tuberculosis (TB) is transmitted by air droplet nuclei, and the etiological agent of the infection is <italic>Mycobacterium tuberculosis</italic> (MTB), which is in the top 10 infectious agents that cause death. 10.8 million people (95% UI: 10.1&#x2013;11.7 million) suffered from TB worldwide in 2023, and drug-resistant TB is a global threat, according to the WHO Global Tuberculosis Report 2024 (<xref ref-type="bibr" rid="B6">Global Tuberculosis Report, 2024</xref>; <xref ref-type="bibr" rid="B36">J et&#xa0;al., 2024</xref>). The host&#x2019;s main defense system determines how TB moves from a latent to an active state. However, the MTB gene can change inside the alveolar macrophage and boosts their ability to defend against the joining of autophagosomes and lysosomes. Infections caused by MTB may manifest as either active tuberculosis disease (ATB) or asymptomatic latent tuberculosis infection (LTBI), which is influenced by the intricate biological properties of MTB and the diverse immunological responses of the host. Although most infections may be eradicated or controlled by a strong immune response, 5%&#x2013;10% of infected individuals will develop ATB during their lifetime. Individuals with compromised immune systems, especially those with untreated HIV infections, are significantly more susceptible to TB compared to those with robust immune systems. The transition from latent to ATB transpires when the MTB circumvent the immune system&#x2019;s defenses and commence proliferation. Some people exhibit active disease quickly after infection, whereas others manifest it later as their immune system declines (<xref ref-type="bibr" rid="B29">Furin et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B1">Aghoram et&#xa0;al., 2025</xref>; <xref ref-type="bibr" rid="B52">Ma et&#xa0;al., 2025</xref>; <xref ref-type="bibr" rid="B54">McCaffrey et&#xa0;al., 2022</xref>). A recent study found that single-cell RNA sequencing (scRNA-seq) increases the amount of low-abundance RNA from single cells and allows for large-scale sequencing to analyze gene activity. Also, this study examined ferroptosis-related gene activity in monocyte subsets. The TB and HC groups differed significantly, suggesting that monocyte-induced ferroptosis may contribute to TB. Non-classical monocytes expressed ferroptosis genes due to abnormal monocyte differentiation during TB development. In brief, ferroptosis protects the host from bacterial infections by suppressing intracellular pathogens through lysosomal and phagocytic processes. MTB may control ferroptosis for growth and immune evasion utilizing <italic>FerrDBV2</italic> (<xref ref-type="bibr" rid="B31">Gao et&#xa0;al., 2023</xref>; <xref ref-type="bibr" rid="B52">Ma et&#xa0;al., 2025</xref>). Some important genes are linked to the progression from LTBI to ATB, and a LASSO analysis found five key genes: <italic>FBXO6, ATF3, GBP1, GBP4</italic>, and <italic>GBP5</italic>. ATB patients significantly elevated the expression levels of the identified hub genes compared to LTBI patients (<xref ref-type="bibr" rid="B18">Chen et&#xa0;al., 2022</xref>). Importantly, IL-6 promotes monocyte proliferation and MTB growth after human hematopoietic stem cell infection. IL-6 activity is also associated with lung function impairment, radiological severity, and extensive TB. Elevated baseline IL-6 activity and SOCS3 induction indicate TB. Th1 cell responses, which regulate microbes, may decrease and promote immunopathology (<xref ref-type="bibr" rid="B33">Hamilton et&#xa0;al., 2025</xref>). Therefore, this review aims to analyze the various factors associated with the progression of LTBI to ATB based on the recent studies data. In this review, the distinct factors associated with the prognosis of LTBI to ATB will be analyzed through the regulation of autophagy by host-microbe interactions, the role of miRNAs in disease prognosis, single-cell RNA sequencing to examine immune responses, and the involvement of monocytes in the progression from LTBI to ATB.</p>
</sec>
<sec id="s2">
<label>2</label>
<title>Factors associated with the progression of tuberculosis</title>
<p>There are significant factors are links with the prognosis of the TB infection. Majorly, the MTB produce some essential genes to lose the autophagosome-lysosome fusion action. Also, other factors bring vital functions to progress the TB infection, likely, miRNAs are small, non-coded, and most of these miRNAs modulated autophagic activity or targeted ATGs to protect mycobacterial survival, contributing to TB pathogenesis. It is unclear how miRNAs alter host defenses during LTBI and if they are clinically relevant (<xref ref-type="bibr" rid="B16">Chen et&#xa0;al., 2020</xref>). Also, diagnostic advancement of single-cell sequencing utilizes to identify the genes associated with the disease progression. Furthermore, early MTB infection, monocytes, the key innate immune cells, defend the host from intracellular infections. Monocyte variety and ability to become macrophages or dendritic cells link innate and adaptive immune responses (<xref ref-type="bibr" rid="B42">Li et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B87">Wayengera et&#xa0;al., 2017</xref>).</p>
<sec id="s2_1">
<label>2.1</label>
<title>Autophagy regulation in the progression of TB</title>
<p>Autophagy, a housekeeping function, maintains intracellular quality control under stress. Both innate and adaptive immunity use autophagy. New vesicles, or phagophores, grow longer and larger during autophagy and develop into the two-membrane autophagosome. The autophagosome becomes a phagolysosome for recycling or degradation after merging with the lysosome (<xref ref-type="bibr" rid="B73">Shariq et&#xa0;al., 2021</xref>). In MTB infection, autophagy has evolved from a canonical degradation pathway to a complex host-pathogen interface. Canonical autophagy, mediated by autophagy related genes (ATG) proteins like <italic>ATG5</italic>, promotes phagosome-lysosome fusion and reduces neutrophil-driven inflammation early in infection, limiting MTB survival in alveolar macrophages. Latest research found that total loss of autophagy components like <italic>ATG7</italic> and <italic>ATG16L1</italic> made the host more susceptible to pathogen-induced phagosome damage and macrophage necrosis (<xref ref-type="bibr" rid="B65">Ren et&#xa0;al., 2025</xref>). The MTB genome encodes eleven eukaryotic-like serine-threonine protein kinases (<italic>STPKs</italic>) regulate virulence, growth, metabolism, and host-pathogen interactions. <italic>PknG</italic> is the only <italic>STPK</italic> released into host cells during infection. PknG also facilitates pathogen survival during MTB infection by inhibiting macrophage phagosome maturation, which is necessary for TB pathogenicity (<xref ref-type="bibr" rid="B32">Ge et&#xa0;al., 2022</xref>). The endoplasmic reticulum (ER) stress mechanisms of MTB cause apoptosis, while autophagy helps cells survive. In contrast, the autophagy inhibition increased MTB-induced apoptosis, suggesting moderate autophagy may protect cells. In this study, <italic>BAG2</italic> (BCL2 associated athanogene 2) increased autophagy to reduce cell death during MTB infection, but autophagy inhibition eliminated its cytoprotective effects. <italic>BAG2</italic>&#x2019;s role in MTB-induced ER stress and apoptosis-autophagy relationships was clarified (<xref ref-type="bibr" rid="B44">Liang et&#xa0;al., 2020</xref>). In addition, MTB infection diminished <italic>H3K9</italic> and <italic>H3K27</italic> acetylation, which is crucial for transcriptional activation, while augmenting <italic>H3K9</italic> and <italic>H3K27</italic> hypermethylation, important for transcriptional repression. These findings suggest that to enhance MTB survival, MTB PRT performs two histone modifications. Certain histone methyltransferases, such as G9a, Suv39h1/h2 (which facilitates H3K9 hypermethylation), and Ezh2 (which promotes H3K27 hypermethylation), induce histone hypermethylation (<xref ref-type="bibr" rid="B71">Sengupta et&#xa0;al., 2021</xref>). In this context, the association between <italic>PE_PGRS</italic> proteins and <italic>Rab1A</italic> enhances the <italic>GTP activity of Rab1A</italic>, hence boosting mTOR and preventing autophagy. Related to <italic>RablA</italic>-positive cells infected with the same mycobacteria, <italic>Rab1A</italic> knockdown cells (<italic>siRab1A</italic>) infected with either wild-type MTB or two complementing strains had reduced mTOR activation (measured by p-S6), suggesting that <italic>Rab1A</italic> regulates mTOR activity (<xref ref-type="bibr" rid="B79">Strong et&#xa0;al., 2021</xref>). Thus, the <italic>PE_PGRS</italic> protein of MTB suppresses the autophagy and capable of survive for g a long time in macrophages. Although, the roles of autophagy in the early detection of the transition from NIHS or LTBI to active TB illness remain largely unexplored. According to a recent study, anti-TB treatment reversed the up-regulation of <italic>LC3B</italic> and <italic>ATG5</italic> in patients with active TB and those with high bacterial burden or advanced disease. These results imply that autophagy flux could be utilized to create tools for tracking the development of TB reactivation disease (<xref ref-type="bibr" rid="B17">Chen et&#xa0;al., 2025</xref>).</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>MicroRNA association with progression of TB</title>
<p>MicroRNAs (miRNAs) are small, non-coding RNA molecules. By binding to the 3&#x2032;-UTR regions of target mRNAs, microRNAs meticulously regulate gene expression at the post-transcriptional level. Since miRNAs have an impact on a wide range of biological functions, including immune regulation, growth, development, homeostasis, and the progression of disease. In this case, <italic>miR-142-3p</italic> was markedly downregulated in macrophages after MTB infection. Specifically, <italic>miR-142-3p</italic> negatively regulated the production of pro-inflammatory mediators (NF-&#x3ba;B, TNF-&#x3b1;, and IL-6) via targeting interleukin receptor associated kinase (<italic>IRAK1</italic>). The precise target of <italic>miR-142-3p</italic> is still ambiguous. This work revealed that miR-142-3p markedly impeded phagosome development in macrophages, mitigated autophagy caused by MTB H37Ra, and enhanced intracellular bacterial survival in macrophages by inhibiting <italic>ATG16L1</italic> and <italic>ATG4c</italic> (<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1</bold></xref>). In contrast, <italic>miR-106a</italic> affects the autophagy process and mycobacterial removal in human macrophages by targeting <italic>ULK1, ATG7</italic>, and <italic>ATG16L1</italic>, which may help us better understand the host&#x2019;s innate immune responses against MTB (<xref ref-type="bibr" rid="B63">Qu et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B47">Liu et&#xa0;al., 2021</xref>). Besides that, circRNA links to the autophagy in MTB infection, since monocytes from TB patients exhibited distinctly reduced levels of hsa_circ_0045474 compared to monocytes from healthy controls. Moreover, circRNAs have been found to participate in the autophagy of TB-associated macrophages. For instance, circRNA-0003528 facilitated MTB-associated macrophage polarization by up-regulating CTLA4 and down-regulating <italic>miR-224-5p, miR-324-5p</italic>, and <italic>miR-488-5p</italic>. Similarly, <italic>hsa_circ_0045474 or miR-582-5p</italic> partially mitigated the influence of <italic>TNKS2</italic> or <italic>miR-582-5p</italic> on macrophage autophagy, suggesting that the <italic>miR-582-5p/TNKS2</italic> axis played a role in the down-regulation of <italic>hsa_circ_0045474</italic> to promote macrophage autophagy in TB (<xref ref-type="table" rid="T1"><bold>Table&#xa0;1</bold></xref>) (<xref ref-type="bibr" rid="B89">Wu et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B35">Huang et&#xa0;al., 2020</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Inhibition of autophagy and role of miRNA in progression of TB. Illustrated that Autophagy in mycobacterial infection. ATGs help cells recognize nutritional or infection signals via the AMPK/mTOR pathway, activate the ULK1 complex, and recruit LC3-II to the phagophore. The phagophore, comprising LC3-II, forms an autophagosome that encloses bacteria, cytosolic organelles, and macromolecules. The autophagosome unites with the lysosome to breakdown cargo as an autophagolysosome. Thus, autophagy targeting mycobacteria involves signal induction, nucleation, growth, and fusion, which are controlled by host and bacterial stimuli. Various miRNAs inhibit the autophagy initiation, expansion, and fusion to enhance the MTB survival (<xref ref-type="bibr" rid="B43">Li et&#xa0;al., 2025</xref>). PE_PGRS proteins help MTB bacteria attach to RablA during infection. Inhibition of Ulk1 complex translocation to the preautophagosome by PE_PGRS and RablA reduces autophagy (<xref ref-type="bibr" rid="B79">Strong et&#xa0;al., 2021</xref>). DC - Dendritic cells.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-16-1666138-g001.tif">
<alt-text content-type="machine-generated">Diagram illustrating the autophagy pathway involving signal induction with AMPK, mTOR, and Ulk1 complex. The process features phagophore formation, expansion, fusion with autophagosome, and recycling through lysosomes. Various molecules such as LC3B-II, p62, and microRNAs like miR-142-3p and miR-23a-5p are labeled, indicating their regulatory roles in inhibiting expansion or fusion. The involvement of Rab1A, PE_PGRS, and autophagosome-lysosome fusion is also depicted.</alt-text>
</graphic></fig>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Different types of genes function in the regulation of autophagy.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="center">Study</th>
<th valign="middle" align="center">Biological marker</th>
<th valign="middle" align="center">Clinical outcome</th>
<th valign="middle" align="center">Technical platform</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="center"><xref ref-type="bibr" rid="B65">Ren et&#xa0;al., 2025</xref></td>
<td valign="middle" align="center">CASP1, FAS, TRIM5, C5</td>
<td valign="middle" align="center">ATB patients had significantly higher CASP1, FAS, TRIM5, and C5 mRNA expression than LTBI and HC patients.</td>
<td valign="middle" align="center">Autophagy related genes (ARG) signature</td>
</tr>
<tr>
<td valign="middle" align="center"><xref ref-type="bibr" rid="B32">Ge et&#xa0;al., 2022</xref></td>
<td valign="middle" align="center">PknG/ LC3-ll puncta/ SQSTM1</td>
<td valign="middle" align="center">Mtb PknG inhibit autophagosome function with kinase activity. Infected cells with WT Mtb, &#x394;pknG:pknG, or &#x394;pknG:pknGK181M strains showed elevated LC3-II and SQSTM1 protein levels.</td>
<td valign="middle" align="center">Western blot</td>
</tr>
<tr>
<td valign="middle" align="center"><xref ref-type="bibr" rid="B44">Liang et&#xa0;al., 2020</xref></td>
<td valign="middle" align="center">BAG2</td>
<td valign="middle" align="center">Selective BAG2-induced autophagosomes combine with lysosomes. The vacuolar H+-ATPase inhibitor bafilomycin A1 (Baf A1) increased autophagic vesicle marker LC3-II, while Bag2 siRNA inhibited this accumulation.</td>
<td valign="middle" align="center">MTB H37Ra-infected BMDMs and RAW264.7 cells, assess autophagosome formation kinetics using western blotting.</td>
</tr>
<tr>
<td valign="middle" align="center"><xref ref-type="bibr" rid="B63">Qu et&#xa0;al., 2021</xref></td>
<td valign="middle" align="center">miR-142-3p</td>
<td valign="middle" align="center">Overexpressing miR-142-3p reduced H37Ra-induced autophagy activation, prevented macrophage phagosome formation, and increased MTB macrophage survival.</td>
<td valign="middle" align="center">MTB infected in RAW264.7 cells</td>
</tr>
<tr>
<td valign="middle" align="center"><xref ref-type="bibr" rid="B47">Liu et&#xa0;al., 2021</xref></td>
<td valign="middle" align="center">miR-106a</td>
<td valign="middle" align="center">Induced miR-106a expression improved intracellular mycobacterial survival, but transfection with miR-106a inhibitors lowered it.</td>
<td valign="middle" align="center">TEM</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>miR, microRNA; TEM, Transmission Electron Microscope; BMDM, Bone marrow derived macrophages;mRNA, messenger Ribonucleic acid; BAG2, BCL2 associated athanogene 2; SQSTM1, sequestosome 1; pknG, protein kinase G; LC3, Microtubule, associated protein 1A/1B light chain 3.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>Extracellular vesicles (EVs) and exosomes, which transport proteins, mRNAs, and non-coding RNAs (ncRNAs), are essential for facilitating intercellular communication among proximate and remote cells, thereby influencing numerous cellular and biological processes. Noticeably, the plasma exosomes from LTBI patients transmitted <italic>miR-7850-5p</italic> to THP1, inhibiting the expression of the critical iron death gene <italic>SLC11A1</italic> and promoting MTB&#x2019;s intracellular survival in THP1 (<xref ref-type="bibr" rid="B21">Cui et&#xa0;al., 2024</xref>; <xref ref-type="bibr" rid="B72">Shahzad et&#xa0;al., 2022</xref>). In addition, <italic>miR-144-3p</italic> has the potential to inhibit the activation of autophagy and enhance BCG infection through its targeting of ATG4a in RAW264.7 cells. In macrophage cells, <italic>miR-23a-5p</italic> may impact autophagy and mycobacterial viability by targeting TLR2 within the TLR2/MyD88/NF-&#x3ba;B signaling pathway during MTB infection (<xref ref-type="bibr" rid="B50">Lyu et&#xa0;al., 2019</xref>).</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Single-cell RNA sequencing in host immune response</title>
<p>Single-cell lung events can cause or control TB. Single-cell technologies like RNA-sequencing (scRNA-seq) can objectively profile immune cell populations in healthy and diseased humans and animals. Although circulating NK cells are highly important in TB immunity, besides the study found CD27+ NK cells in macaque hosts&#x2019; lungs that regulate MTB infection. Memory-like responses and vaccine-induced MTB protection depend on CD27+ NK cell recognition, proliferation, and survival. The TNF receptor superfamily member CD27 may indicate mature or memory natural killer cells. In cytotoxicity, cytokine production, proliferation, and function, CD27+ NK cells outperform CD27-NK cells. Also, this study findings support NK cell TB protection. In LTBI patients, mycobacteria increase CD27+ NK cell growth. Human monocytes and AMs infected with MTB can be lysed by NK cells to boost immunity (<xref ref-type="bibr" rid="B25">Esaulova et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B83">Venkatasubramanian et&#xa0;al., 2017</xref>). Also, a similar study scRNA-seq analyzed distribution of &#x3b3;&#x3b4;T cell sub-clusters across the tested groups indicated that latent MTB infection induces a specific proliferation of CD81bright &#x3b3;&#x3b4; T cells, skewing them towards AKT signaling, which is mediated by PI3K and involves cell activation through the second messenger PIP3. The PI3K/AKT pathway is a crucial signaling cascade that regulates metabolism, cellular growth, and survival (<xref ref-type="bibr" rid="B74">Shekarkar Azgomi et&#xa0;al., 2024</xref>). Furthermore, in CyTOF analysis reveals that non-progressing LTBI patients have fewer MAIT, NKT, and NK cells than those with PTB, suggesting lower microbial abundance. These cells are essential for mycobacteria regulation. PBMCs of LTBI patients who developed PTB had more CD16+CD56dimCD57+ early NK cells. Antigen-dependent cell cytotoxicity (ADCC) indicates microbicidal activity via CD16 (Fc gamma receptor III), while reduced CD56 and elevated CD57 indicate cellular senescence. Compared to active pulmonary TB (PTB), latent TB infection progression may have more CD16+CD56dimCD57+ early natural killer (NK) cells, suggesting the involvement of antibody-dependent cellular cytotoxicity (ADCC) cells that regulate organisms. In addition, the MAIT NKT cells contribute significantly to the initial response to mycobacteria and are effectively equipped with cytotoxic molecules through granzyme B activity (<xref ref-type="bibr" rid="B39">Kamolratanakul et&#xa0;al., 2024</xref>; <xref ref-type="bibr" rid="B67">Ruibal et&#xa0;al., 2021</xref>). In a recent study indicates that these distinct genes are essential for TB that gp91-phox subunit of the phagocytic oxidase complex, responsible for producing superoxide and other reactive oxygen species necessary for microbial destruction, is encoded by the <italic>CYBB</italic> gene. <italic>CYBB</italic> overexpression elevates reactive oxygen species (ROS), which can damage tissue and initiate clinical symptoms associated with LTBI. The ROS have historically been considered responsible for tissue damage in both acute and chronic inflammatory diseases. Notably, this study employed machine learning algorithms Lasso, random forest (RF), and SVM-RFE to identify specific genes associated with TB development and the inflammatory response (<xref ref-type="bibr" rid="B51">Ma et&#xa0;al., 2023</xref>; <xref ref-type="bibr" rid="B28">Fraz&#xe3;o et&#xa0;al., 2015</xref>). In brief, to comprehend gp91phox, historically referred to as cytochrome b558, reveals that the NOX2 core complex comprises two transmembrane subunits: the auxiliary p22phox (p22) subunit and the catalytic NOX2 subunit, also known as gp91phox (<xref ref-type="bibr" rid="B60">Noreng et&#xa0;al., 2022</xref>). Recent findings from flow cytometry and single-cell RNA sequencing indicate an increase in the fraction of monocytes associated with active TB. However, the pathophysiology of TB, mortality was associated with monocyte dysfunction and the activation of the innate immune system (<xref ref-type="bibr" rid="B37">Janssen et&#xa0;al., 2017</xref>).</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Monocytes associated with LTBI to ATB</title>
<p>The fatal illness TB is associated with monocytes. Though, numerous studies have demonstrated that autoimmunity has a role in TB. The innate and adaptive immune systems are essential for combating MTB. Cells of the innate and adaptive immune responses are involved in TB granuloma, with a particular emphasis on monocytes. In a recent study, the PPI network contained three essential monocyte-related genes <italic>SERPINA1, FUCA2</italic>, and <italic>HP</italic>. <italic>Haptoglobin (HP)</italic> is the only gene directly connected to TB development and activity. In an acute-phase response, the haptoglobin protein aids tissue repair, infection prevention, and internal environment stability. In TB pleurisy, HP expression is high (<xref ref-type="bibr" rid="B42">Li et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B30">Gao et&#xa0;al., 2019</xref>). The study&#x2019;s clinical sample verification found that active TB patients&#x2019; PBMCs had higher HP levels than latent TB and healthy controls. This study suggested that tissue hypoxia raises HP levels in active TB. Under hypoxia, many red blood cells lysed, raising tissue hemoglobin levels. As hemoglobin is absorbed, haptoglobin expression rises. Patients with active TB were sensitive. Serine protease inhibitor A1 (SERPINA1) inhibits over 90% of plasma proteases due to its highly conserved protein structure. Arya et&#xa0;al. found that active TB had high <italic>SERPINA1</italic> expression using the <italic>iTRAQ-I</italic> experiment and Western blotting. Acute-phase reactive protein is mostly produced by liver cells, however epithelial, monocyte, and macrophages can also manufacture it. Active TB also causes lung inflammation (<xref ref-type="bibr" rid="B42">Li et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B5">Arya et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B95">Zoller et&#xa0;al., 2018</xref>). Notably, the PTB patients displayed a diminished proportion of CD14+CD16&#x2212; monocytes and an increased prevalence of CD14+CD16+ and CD14&#x2212;CD16+ monocytes in comparison to healthy controls. Monocytes contain CD163, a scavenger receptor that endocytoses haptoglobin-hemoglobin complexes and is indicative of M2 macrophages (<xref ref-type="bibr" rid="B14">Canton et&#xa0;al., 2013</xref>). The proliferation of CD16+CD163+MerTK+ monocytes in TB diminishes the host&#x2019;s defense against MTB due to their reduced pro-/anti-inflammatory cytokine production ratio and restricted T cell activation. CD163 and MerTK signify M2-like macrophage activation, characterized by immunomodulatory and pathogen-permissive properties (<xref ref-type="bibr" rid="B48">Liu et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B41">Lastrucci et&#xa0;al., 2015</xref>). To comprehend the <italic>DosR</italic> (dormancy of survival) regulon in the LTBI state, a segment of the MTB genome activated during dormancy comprises 50 genes. Patients with LTBI exhibit more pronounced immune responses to these antigens compared to those with active TB, hence facilitating the differentiation between infection and disease (<xref ref-type="bibr" rid="B55">Meier et&#xa0;al., 2018</xref>). These antigens may help assess ATB treatment success as well as distinguish LTBI from ATB. The most promising M. tuberculosis <italic>DosR</italic> regulon encoded antigens were <italic>Rv0081, Rv1733c, Rv1737c, Rv2029c</italic>, and <italic>Rv2628</italic>, which showed immunogenic potential across studies and regions. The <italic>DosR</italic> regulon&#x2019;s transcriptional regulator <italic>Rv0081</italic> may be important in hypoxia. Long-term incubation studies in Ethiopia and South Africa showed this antigen&#x2019;s immunogenicity (<xref ref-type="bibr" rid="B56">Mensah et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B3">Araujo et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B7">Bai et&#xa0;al., 2016</xref>). The median monocyte-to-lymphocyte ratio (MLR) in IGRA+ subgroup B was 0.52, greater than subgroup A (0.35, p = 0.04). This ratio is linked to blood transcriptomes and TB risk. However, the IGRA+ B subgroup, MLR level increased marginally (<xref ref-type="bibr" rid="B11">Broderick et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B59">Naranbhai et&#xa0;al., 2015</xref>).</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>Future perspectives on targeting biomarkers on TB prognosis</title>
<p>Multiple factors contribute to the progression of TB, particularly as MTB employs various genes for intracellular survival. Analyses of the transcriptome and proteome facilitate the development of diagnostic markers and antimycobacterial agents. Small RNAs, including miRNA, lncRNA, circRNA, and the ceRNA network, will have important roles in gene regulation and translational research. In this context, numerous miRNAs are essential in the regulation of autophagy; specifically, <italic>miR-155</italic> inhibits autophagy in human dendritic cells by targeting <italic>ATG3</italic>. In macrophages infected with MTB, <italic>miR-17-5p</italic> regulates autophagy by targeting <italic>Mcl-1</italic> and <italic>STAT3</italic>. <italic>MiR-27a</italic> facilitates the survival of MTB within cells by modulating Ca2+-associated autophagy. In human monocytes and macrophages, <italic>miR-144-5p</italic> suppresses antibacterial autophagy and the innate immune response to MTB by targeting <italic>DRAM2</italic>. MTB inhibits integrated autophagic pathways that promote bacterial intracellular survival and persistence through the production of <italic>miR-33</italic> and <italic>miR-33*.</italic> Research indicates that <italic>miR-20a</italic> targets <italic>ATG7</italic> and <italic>ATG16L1</italic>, resulting in reduced autophagy and increased BCG survival in murine macrophages (<xref ref-type="bibr" rid="B27">Etna et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B45">Liu et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B40">Kim et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B47">Liu et&#xa0;al., 2021</xref>). Thus, analyses of small RNAs and their interaction with autophagy in clinical strains will identify potential diagnostic markers. Pathogenic mycobacteria expressing PE and PPE families inhibit autophagy, thereby enhancing bacterial survival within macrophages during host-microbe interactions. The expression of PE or PPE proteins markedly enhanced mTOR signaling in <italic>Mycobacterium smegmatis</italic>, indicating a potential mechanism for the inhibition of autophagy induced by mycobacteria (<xref ref-type="bibr" rid="B78">Strong et&#xa0;al., 2020</xref>). This analysis of mycobacterial self-defense mechanisms against autophagosome-lysosome fusion presents a promising tool for the development of antimycobacterial agents.</p>
</sec>
</sec>
<sec id="s3" sec-type="discussion">
<label>3</label>
<title>Discussion</title>
<p>This review provides a comprehensive analysis of the factors associated with the progression of LTBI to ATB. Majorly, various types of genes significantly modulate the immune responses of MTB and host interactions (<xref ref-type="table" rid="T2"><bold>Table&#xa0;2</bold></xref>). Particularly, analyses of autophagy-regulated genes and their association with MTB survival are crucial to determine the disease prognosis, a vital cellular response to mycobacterial infection, has garnered significant attention. The PE and PPE proteins identified as regulators of autophagy in infected cells comprise <italic>PE_PGRS47, PE_PGRS41, MMAR_0242</italic>, and <italic>PE_PGRS29</italic>. This protein&#x2019;s role in inhibiting autophagy in MTB-infected cells is highlighted by the identification of a Tn insertion mutation in the gene encoding <italic>PE_PGRS47</italic> (<xref ref-type="bibr" rid="B78">Strong et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B68">Saini et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B22">Deng et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B15">Chai et&#xa0;al., 2019</xref>). In addition, <italic>SIRT4</italic>, a member of the sirtuin family, is located in the mitochondria. The functions encompass substrate-specific deacetylase, lipoamidase, ADP-ribosyltransferase, and deacetylase activities. <italic>SIRT4</italic> is also associated with cellular defense mechanisms against microorganisms. In cells treated with LPS, the overexpression of <italic>SIRT4</italic> enhanced steroidogenesis and reduced apoptosis, thereby promoting the dissemination of MTB infection and the activation of LTBI (<xref ref-type="bibr" rid="B57">Min et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B64">Ramatchandirin et&#xa0;al., 2016</xref>). The &#x201c;risk of progression to ATB&#x201d; signature exhibited a significant correlation with the LTBI-Risk treatment signature. Four predictive gene profiles (<italic>BATF2, RISK6, Zak16</italic>, and <italic>Sweeney3</italic>) indicated that LTBI-Risk patients exhibiting elevated expression of genes linked to the &#x201c;risk of progression to ATB&#x201d; post anti-TB treatment demonstrated significant downregulation of numerous genes. In contrast to therapy-unaffected genes, these genes exhibited enrichment for IFN signaling and functional protein-protein interactions (<xref ref-type="bibr" rid="B13">Burel et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B92">Zak et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B81">Sweeney et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B85">Warsinske et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B66">Roe et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B61">Penn-Nicholson et&#xa0;al., 2020</xref>).</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Clinical immune responses in progression of TB infection.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="center">Study</th>
<th valign="middle" align="center">Biological marker</th>
<th valign="middle" align="center">Clinical outcome</th>
<th valign="middle" align="center">Study population/ Technical platform</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="center"><xref ref-type="bibr" rid="B83">Venkatasubramanian et&#xa0;al., 2017</xref></td>
<td valign="middle" align="center">IL-21</td>
<td valign="middle" align="center">CD3-CD56+CD27+ cells inhibit M. tb H37Rv growth in macrophages more than CD3-CD56+CD27- cells. Unlike scrambled siRNA, IL-21 siRNA inhibited ESAT6-dependent NKp46+CD27+KLRG1+ cell growth.</td>
<td valign="middle" align="center">12 individuals in positive QuantiFERON-TB Gold tests- (+)LTBI, while 12 others had negative tests- HC.</td>
</tr>
<tr>
<td valign="middle" align="center"><xref ref-type="bibr" rid="B74">Shekarkar Azgomi et&#xa0;al., 2024</xref></td>
<td valign="middle" align="center">CD81+bright &#x3b3;&#x3b4;+</td>
<td valign="middle" align="center">TBI samples have increased IL2RB, ICOS, LTB, GPX4, and CD79B. However, SYT11, CD81, XBP1, and GPX4 changed synchronously in the IL-2-STAT5 signaling pathway. TBI also leads to an increase of CD81+bright &#x3b3;&#x3b4;+ T cell subsets.</td>
<td valign="middle" align="center">Total-15 participants were enrolled: ATB-5, with TBI-5, and HD-5.</td>
</tr>
<tr>
<td valign="middle" align="center"><xref ref-type="bibr" rid="B39">Kamolratanakul et&#xa0;al., 2024</xref></td>
<td valign="middle" align="center">MAIT NKT</td>
<td valign="middle" align="center">People with latent tuberculosis infection (LTBI) had more MAIT NKT cells than those with active PTB and healthy controls. In addition, 6 of 17 (35%) LTBI patients advanced to active PTB and had more MAIT NKT cells and early NKT cells than those without progression.</td>
<td valign="middle" align="center">A total of 32 subjects (12 PTB, 17 LTBI, 3 healthy volunteers)</td>
</tr>
<tr>
<td valign="middle" align="center"><xref ref-type="bibr" rid="B48">Liu et&#xa0;al., 2019</xref></td>
<td valign="middle" align="center">CD14+CD16+</td>
<td valign="middle" align="center">Patients with PTB had higher rates of CD14+CD16+ monocytes (15.7% vs 7.8%, P &lt; 0.0001), CD14-CD16+ monocytes (5.3% vs 2.5%, P = 0.0011), and lower percentage of CD14+CD16-cells (51.0% vs 70.4%, P = 0.0110) compared to healthy controls (HC</td>
<td valign="middle" align="center">129 people included, LTBI= 20, malignant pleural effusion (MPE) = 21), PTB= 39), tuberculous pleurisy = 28), healthy controls = 21.</td>
</tr>
<tr>
<td valign="middle" align="center"><xref ref-type="bibr" rid="B24">Ding et&#xa0;al., 2025</xref></td>
<td valign="middle" align="center">CD4+/CD8+ T-cell</td>
<td valign="middle" align="center">The intermediate CD4+/CD8+ T-cell ratio in LTBI cases indicated dynamic immunological balance. The tuberculosis cohort had more inflammatory T-cells and CD8+ T-cell-mediated MHC-I and BTLA signaling.</td>
<td valign="middle" align="center">Single-cell RNA sequencing (scRNA-seq) -evaluate PBMCs from 7 people: 2 HC, 2-LTBI patients, and 3-active tuberculosis (ATB) patients.</td>
</tr>
<tr>
<td valign="middle" align="center"><xref ref-type="bibr" rid="B73">Shariq et&#xa0;al., 2021</xref></td>
<td valign="middle" align="center"><italic>RipA</italic></td>
<td valign="middle" align="center">In response to <italic>RipA</italic>, macrophages produce pro-inflammatory cytokines TNF-&#x3b1;, IL-6, and IL-12 in a dose- and time-dependent manner. Additionally, TLR4 recognizing RipA can lead to macrophages releasing IL-6, IL-12, and TNF-&#x3b1;.</td>
<td valign="middle" align="center">In-silico</td>
</tr>
<tr>
<td valign="middle" align="center"><xref ref-type="bibr" rid="B79">Strong et&#xa0;al., 2021</xref></td>
<td valign="middle" align="center"><italic>PE_PGRS20 &amp; 47, Rab1A</italic></td>
<td valign="middle" align="center"><italic>Rab1A</italic> with <italic>PE_PGRS20</italic> or <italic>PE_PGRS47</italic> reduced proinflammatory cytokine production and MHC class II-restricted antigen presentation.</td>
<td valign="middle" align="center">immunoblots/ Infection of RAW 264.7 macrophages</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>MTB, Mycobacterium tuberculosis; H37Rv, Human 37 Rough virulent; siRNA, small interfering RNA; ESAT6, Early Secreted Antigenic Target 6; LTBI, Latent TB infection; PTB, Pulmonary TB; TLR, Toll like Receptor; IL, Interleukin; PE_PGRS, polymorphic GC, rich repetitive sequence; TNF, Tumour necrosis factor; MHC, 1, Major Histocompatibility Complex, 1; CD14 &amp;16, Cluster of Differentiation 14&amp;16; MAIT NKT cells, Natural Killer T (NKT) and Mucosal, Associated Invariant T (MAIT) cells.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>Multiple studies show that TB increases complement component gene expression. TB genes had higher <italic>C1q</italic>-encoding gene expression than LTBI and other lung illnesses. However, whole blood RNA studies reveal monocytes or macrophages promote <italic>C1q</italic> gene transcription (<xref ref-type="bibr" rid="B49">Lubbers et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B70">Scriba et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B38">Jiang et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B8">Blankley et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B62">Petrilli et&#xa0;al., 2020</xref>). The transcriptome study of differentially expressed genes (DEGs) associated in TB development showed that <italic>miR-155</italic> targeted Rheb to increase macrophage autophagy to eliminate intracellular Mycobacteria. However, <italic>miR-155</italic> targets <italic>ATG3</italic> to inhibit human dendritic cell autophagy. <italic>MiR-17-5p</italic> targets <italic>Mcl-1</italic> and <italic>STAT3</italic> to control autophagy in MTB-infected macrophages (<xref ref-type="bibr" rid="B47">Liu et&#xa0;al., 2021</xref>). So DEGs analysis is critical for ATB and LTBI. Also, <italic>SULT1A3</italic>, connected to treatment success in adults with TB, and <italic>NCOA3</italic>, which showed differential miRNA expression between hospitalized TB patients and controls. <italic>DEFA1</italic> and <italic>DEFA3</italic>, biomarkers for differentiating ATB and LTBI in children, predicted TST conversion better (<xref ref-type="bibr" rid="B9">Bobak et&#xa0;al., 2023</xref>; <xref ref-type="bibr" rid="B25">Esaulova et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B75">Silva et&#xa0;al., 2021</xref>).</p>
<p>The WHO recommends various diagnostic approaches to identify high-risk populations and expedite the detection and treatment of TB (<xref ref-type="bibr" rid="B93">Zhang et&#xa0;al., 2025</xref>). Whole-genome microarrays and, to a lesser extent, RNA-seq have shown that analyzing gene activity can elucidate the mechanisms of infection spread (<xref ref-type="bibr" rid="B26">Est&#xe9;vez et&#xa0;al., 2020</xref>). However, the recent study supports a substantial correlation between disease progression and transcriptome-associated genes that aid in the survival of intracellular bacilli in macrophages (<italic>ORL1</italic>). Also, genes that code for two carriers of cobalamin (vitamin B12), a metabolite that might be involved in MTB pathogenesis. ATB patients may have better vitamin B12 absorption and bacterial survival if their expression of those carriers is higher. In addition, another study revealed that the crucial role of transcriptome data was supported by the upregulation of syndecans (<italic>SDC1, SDC3</italic>, and <italic>SDC4</italic>), the complement cascade, and type I and II interferon signaling in TB patients (<xref ref-type="bibr" rid="B77">Singhania et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B69">Sambarey et&#xa0;al., 2017</xref>).</p>
<p>On the other hand, host immune response and MTB survival must be examined. CCRL2 is engaged in C-C chemokine ligand type 2 signaling, MAPK14 is a mitogen-activated protein kinase 14, and MSR1 is a receptor involved in TB progression/phagocytosis and destruction. B, CD4+, and CD8+ T cells are adaptive immune cells. Depletion of CD4+ T cells, like HIV infection, increases TB risk (<xref ref-type="bibr" rid="B58">Nangpal et&#xa0;al., 2025</xref>). A subsequent transcriptome study of LTBI&#x2019;s hematological immune-mediated features confirmed the findings. LTBI patients had more active memory CD4+ and CD8+ T cells, cytolytic activity, and T-cell co-inhibition. This supports recent findings that persistent infections require enhanced cytolytic activity and regulatory mechanisms to maintain immunological homeostasis (<xref ref-type="bibr" rid="B46">Liu et&#xa0;al., 2025</xref>; <xref ref-type="bibr" rid="B10">Bolivar-Wagers et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B82">Teh et al., 2022</xref>), IL-18 is essential for IFN-&#x3b3; production, hence decreased levels indicate a less adaptive immune response. Reduced IL-18 levels enhance MTB growth since interferon-gamma is related with the T-helper type 1 profile, which fights this infection. TNF-&#x3b1; expression is crucial for preserving tuberculous granulomas and avoiding LTBI reactivation (<xref ref-type="bibr" rid="B23">de Oliveira Rezende et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B12">Buha et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B76">Silva et&#xa0;al., 2018</xref>). The CD38+CD27 pattern of CD4 T cells distinguished active pulmonary tuberculosis (PTB) from non-tuberculosis (<xref ref-type="bibr" rid="B91">Yang et&#xa0;al., 2025</xref>). Disease development depends on MTB culture filtrate protein-10 (CFP-10), early secreted antigenic target-6 (ESAT-6), and purified protein derivative (PPD) antigenicity. PPD activation may increase transcriptional gene profile differentiation, prompting a larger range of host immune responses (<xref ref-type="bibr" rid="B84">Wang et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B90">Wu et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B19">Clifford et&#xa0;al., 2019</xref>).</p>
<p>Key genetic components of protective immunity in human TB include TNF-A, IL-1B, IFN-&#x3b3;, and TLR-2. TLR4 rs4986791, TLR2 rs5743708, TNFA rs361525, IL1B rs1143627, and IFNG rs2430561 are immune-related SNPs associated with tuberculosis susceptibility (<xref ref-type="bibr" rid="B20">Cubillos-Angulo et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B94">Zhou et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B88">Wei et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B2">Amaral et&#xa0;al., 2018</xref>). Active TB and LTB patients have much greater IL-18 and IL-18BP mRNA levels than healthy controls. This may indicate that immune cell signaling pathways are constantly stimulated during MTB infection to control or promote active TB. IL-18BP, an endogenous inhibitor, controls IL-18 levels. Normal plasma IL-18BP is 20 times higher than IL-18, preventing IL-18 from attaching to its cellular receptor. Chromosome 11 contains the IL-18BP gene at 11q13.4. Two response elements in the mRNA promoter region control gene expression and protein synthesis after IFN-&#x3b3; attachment. Thus, biological indicators are molecular diagnostics for LTBI and ATB (<xref ref-type="bibr" rid="B86">Wawrocki et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B34">Hong et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B24">Ding et&#xa0;al., 2025</xref>).</p>
<p>In <italic>DosR</italic> regulon, the dominant T cell antigen and transmembrane protein <italic>Rv1733c</italic> is revealed via bioinformatics. This antigen triggers higher immune responses in LTBI patients than ATB and healthy controls. In the top 45 of 189 antigens was <italic>Rv2628</italic>. Its purpose is unclear. Many studies found that LTBI patients had better immune responses than ATB patients. Additionally, <italic>Rv2031c</italic> (&#x3b1;-crystallin or heat shock protein X) is a crucial <italic>DosR</italic> regulon antigen for MTB growth in macrophages during latency. <italic>Rv1737c</italic> may carry nitrate. Four long-term immunogenicity tests showed LTBI patients outperformed ATB patients. <italic>Rv2029c</italic>, a glycolysis-related phosphofructokinase, has been studied in mice as a vaccine candidate (<xref ref-type="bibr" rid="B80">Su et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B4">Arroyo et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B55">Meier et&#xa0;al., 2018</xref>). In addition, the ML ratio captures monocyte qualitative changes better than monocyte counts, which may explain its epidemiologic linkages. The recent research and enrichment of interferon signaling imply that type I and type II interferons vary the ML ratio and monocyte function enough to explain changed disease history, consistent with their major involvement in mycobacterial and inflammatory disorders (<xref ref-type="bibr" rid="B59">Naranbhai et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B53">Mayer-Barber et&#xa0;al., 2014</xref>).</p>
</sec>
<sec id="s4" sec-type="conclusions">
<label>4</label>
<title>Conclusion</title>
<p>This review analyzes the recent research on factors linked to the progression from latent to active TB. Mycobacterial genes that regulate autophagy play a critical role in disease prognosis. The T-cell-mediated immune response and transcriptome functions in TB prognosis enable the differentiation between active and latent tuberculosis, improve disease prognosis, facilitate the identification of diagnostic biomarkers, and address the existing research gap.</p>
</sec>
</body>
<back>
<sec id="s5" sec-type="author-contributions">
<title>Author contributions</title>
<p>KS: Conceptualization, Data curation, Formal analysis, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. VP: Formal Analysis, Resources, Supervision, Validation, Visualization, Writing &#x2013; review &amp; editing.</p></sec>
<sec id="s7" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec>
<sec id="s8" sec-type="correction-statement">
<title>Correction note</title>
<p>A correction has been made to this article. Details can be found at: <ext-link xlink:href="https://doi.org/10.3389/fcimb.2026.1817346" ext-link-type="uri">10.3389/fcimb.2026.1817346</ext-link>.</p></sec>
<sec id="s9" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declared that generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p></sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Aghoram</surname> <given-names>P.</given-names></name>
<name><surname>Shanmugam</surname> <given-names>P.</given-names></name>
<name><surname>Selvabai</surname> <given-names>R. A. P.</given-names></name>
</person-group> (<year>2025</year>). 
<article-title>The spectrum of extra pulmonary tuberculosis: Emphasizing the importance of microbiological diagnosis- A case series</article-title>. <source>Indian J. Tuberculosis</source> <fpage>168</fpage>&#x2013;<lpage>176</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ijtb.2025.06.004</pub-id>, PMID: <pub-id pub-id-type="pmid">41360582</pub-id>
</mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Amaral</surname> <given-names>E. P.</given-names></name>
<name><surname>Riteau</surname> <given-names>N.</given-names></name>
<name><surname>Moayeri</surname> <given-names>M.</given-names></name>
<name><surname>Maier</surname> <given-names>N.</given-names></name>
<name><surname>Mayer-Barber</surname> <given-names>K. D.</given-names></name>
<name><surname>Pereira</surname> <given-names>R. M.</given-names></name>
<etal/>
</person-group>. (<year>2018</year>). 
<article-title>Lysosomal cathepsin release is required for NLRP3-inflammasome activation by <italic>mycobacterium tuberculosis</italic> in infected macrophages</article-title>. <source>Front. Immunol.</source> <volume>9</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2018.01427</pub-id>, PMID: <pub-id pub-id-type="pmid">29977244</pub-id>
</mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Araujo</surname> <given-names>L. S.</given-names></name>
<name><surname>da Silva</surname> <given-names>N. B. M.</given-names></name>
<name><surname>da Silva</surname> <given-names>R. J.</given-names></name>
<name><surname>Leung</surname> <given-names>J. A. M.</given-names></name>
<name><surname>Mello</surname> <given-names>F. C. Q.</given-names></name>
<name><surname>Saad</surname> <given-names>M. H. F.</given-names></name>
</person-group> (<year>2015</year>). 
<article-title>Profile of interferon-gamma response to latency-associated and novel <italic>in vivo</italic> expressed antigens in a cohort of subjects recently exposed to Mycobacterium tuberculosis</article-title>. <source>Tuberculosis (Edinburgh Scotland)</source> <volume>95</volume>, <fpage>751</fpage>&#x2013;<lpage>757</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tube.2015.08.002</pub-id>, PMID: <pub-id pub-id-type="pmid">26421415</pub-id>
</mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Arroyo</surname> <given-names>L.</given-names></name>
<name><surname>Rojas</surname> <given-names>M.</given-names></name>
<name><surname>Franken</surname> <given-names>K. L.</given-names></name>
<name><surname>Ottenhoff</surname> <given-names>T. H.</given-names></name>
<name><surname>Barrera</surname> <given-names>L. F.</given-names></name>
</person-group> (<year>2016</year>). 
<article-title>Multifunctional T cell response to dosR and rpf antigens is associated with protection in long-term mycobacterium tuberculosis-infected individuals in Colombia</article-title>. <source>Clin. Vaccine immunology: CVI</source> <volume>23</volume>, <fpage>813</fpage>&#x2013;<lpage>824</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/CVI.00217-16</pub-id>, PMID: <pub-id pub-id-type="pmid">27489136</pub-id>
</mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Arya</surname> <given-names>R.</given-names></name>
<name><surname>Dabral</surname> <given-names>D.</given-names></name>
<name><surname>Faruquee</surname> <given-names>H. M.</given-names></name>
<name><surname>Mazumdar</surname> <given-names>H.</given-names></name>
<name><surname>Patgiri</surname> <given-names>S. J.</given-names></name>
<name><surname>Deka</surname> <given-names>T.</given-names></name>
<etal/>
</person-group>. (<year>2020</year>). 
<article-title>Serum small extracellular vesicles proteome of tuberculosis patients demonstrated deregulated immune response</article-title>. <source>Proteomics. Clin. Appl.</source> <volume>14</volume>, <fpage>e1900062</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/prca.201900062</pub-id>, PMID: <pub-id pub-id-type="pmid">31532894</pub-id>
</mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="book">(<year>2024</year>). <source>Global tuberculosis report 2024</source> (<publisher-loc>Geneva</publisher-loc>: 
<publisher-name>World Health Organization</publisher-name>).
</mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Bai</surname> <given-names>X. J.</given-names></name>
<name><surname>Liang</surname> <given-names>Y.</given-names></name>
<name><surname>Yang</surname> <given-names>Y. R.</given-names></name>
<name><surname>Feng</surname> <given-names>J. D.</given-names></name>
<name><surname>Luo</surname> <given-names>Z. P.</given-names></name>
<name><surname>Zhang</surname> <given-names>J. X.</given-names></name>
<etal/>
</person-group>. (<year>2016</year>). 
<article-title>Potential novel markers to discriminate between active and latent tuberculosis infection in Chinese individuals</article-title>. <source>Comp. immunology Microbiol. Infect. Dis.</source> <volume>44</volume>, <fpage>8</fpage>&#x2013;<lpage>13</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cimid.2015.11.002</pub-id>, PMID: <pub-id pub-id-type="pmid">26851588</pub-id>
</mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Blankley</surname> <given-names>S.</given-names></name>
<name><surname>Graham</surname> <given-names>C. M.</given-names></name>
<name><surname>Levin</surname> <given-names>J.</given-names></name>
<name><surname>Turner</surname> <given-names>J.</given-names></name>
<name><surname>Berry</surname> <given-names>M. P.</given-names></name>
<name><surname>Bloom</surname> <given-names>C. I.</given-names></name>
<etal/>
</person-group>. (<year>2016</year>). 
<article-title>A 380-gene meta-signature of active tuberculosis compared with healthy controls</article-title>. <source>Eur. Respir. J.</source> <volume>47</volume>, <fpage>1873</fpage>&#x2013;<lpage>1876</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1183/13993003.02121-2015</pub-id>, PMID: <pub-id pub-id-type="pmid">27076596</pub-id>
</mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Bobak</surname> <given-names>C. A.</given-names></name>
<name><surname>Botha</surname> <given-names>M.</given-names></name>
<name><surname>Workman</surname> <given-names>L.</given-names></name>
<name><surname>Hill</surname> <given-names>J. E.</given-names></name>
<name><surname>Nicol</surname> <given-names>M. P.</given-names></name>
<name><surname>Holloway</surname> <given-names>J. W.</given-names></name>
<etal/>
</person-group>. (<year>2023</year>). 
<article-title>Gene expression in cord blood and tuberculosis in early childhood: A nested case-control study in a South African birth cohort</article-title>. <source>Clin. Infect. diseases: an Off. Publ. Infect. Dis. Soc. America</source> <volume>77</volume>, <fpage>438</fpage>&#x2013;<lpage>449</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/cid/ciad268</pub-id>, PMID: <pub-id pub-id-type="pmid">37144357</pub-id>
</mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Bolivar-Wagers</surname> <given-names>S.</given-names></name>
<name><surname>Larson</surname> <given-names>J. H.</given-names></name>
<name><surname>Jin</surname> <given-names>S.</given-names></name>
<name><surname>Blazar</surname> <given-names>B. R.</given-names></name>
</person-group> (<year>2022</year>). 
<article-title>Cytolytic CD4+ and CD8+ Regulatory T-cells and implications for developing immunotherapies to combat graft-versus-host disease</article-title>. <source>Front. Immunol.</source> <volume>13</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2022.864748</pub-id>, PMID: <pub-id pub-id-type="pmid">35493508</pub-id>
</mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Broderick</surname> <given-names>C.</given-names></name>
<name><surname>Cliff</surname> <given-names>J. M.</given-names></name>
<name><surname>Lee</surname> <given-names>J. S.</given-names></name>
<name><surname>Kaforou</surname> <given-names>M.</given-names></name>
<name><surname>Moore</surname> <given-names>D. A.</given-names></name>
</person-group> (<year>2021</year>). 
<article-title>Host transcriptional response to TB preventive therapy differentiates two sub-groups of IGRA-positive individuals</article-title>. <source>Tuberculosis (Edinburgh Scotland)</source> <volume>127</volume>, <elocation-id>102033</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tube.2020.102033</pub-id>, PMID: <pub-id pub-id-type="pmid">33524936</pub-id>
</mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Buha</surname> <given-names>I.</given-names></name>
<name><surname>&#x160;kodri&#x107;-Trifunovi&#x107;</surname> <given-names>V.</given-names></name>
<name><surname>Ad&#x17e;i&#x107;-Vuki&#x10d;evi&#x107;</surname> <given-names>T.</given-names></name>
<name><surname>Ili&#x107;</surname> <given-names>A.</given-names></name>
<name><surname>Blanka-Proti&#x107;</surname> <given-names>A.</given-names></name>
<name><surname>Stjepanovic</surname> <given-names>M.</given-names></name>
<etal/>
</person-group>. (<year>2019</year>). 
<article-title>Relevance of TNF-&#x3b1;, IL-6 and IRAK1 gene expression for assessing disease severity and therapy effects in tuberculosis patients</article-title>. <source>J. infection developing countries</source> <volume>13</volume>, <fpage>419</fpage>&#x2013;<lpage>425</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3855/jidc.10949</pub-id>, PMID: <pub-id pub-id-type="pmid">32053511</pub-id>
</mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Burel</surname> <given-names>J. G.</given-names></name>
<name><surname>Singhania</surname> <given-names>A.</given-names></name>
<name><surname>Dubelko</surname> <given-names>P.</given-names></name>
<name><surname>Muller</surname> <given-names>J.</given-names></name>
<name><surname>Tanner</surname> <given-names>R.</given-names></name>
<name><surname>Parizotto</surname> <given-names>E.</given-names></name>
<etal/>
</person-group>. (<year>2021</year>). 
<article-title>Distinct blood transcriptomic signature of treatment in latent tuberculosis infected individuals at risk of developing active disease</article-title>. <source>Tuberculosis (Edinburgh Scotland)</source> <volume>131</volume>, <elocation-id>102127</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tube.2021.102127</pub-id>, PMID: <pub-id pub-id-type="pmid">34555657</pub-id>
</mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Canton</surname> <given-names>J.</given-names></name>
<name><surname>Neculai</surname> <given-names>D.</given-names></name>
<name><surname>Grinstein</surname> <given-names>S.</given-names></name>
</person-group> (<year>2013</year>). 
<article-title>Scavenger receptors in homeostasis and immunity</article-title>. <source>Nat. Rev. Immunol.</source> <volume>13</volume>, <fpage>621</fpage>&#x2013;<lpage>634</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nri3515</pub-id>, PMID: <pub-id pub-id-type="pmid">23928573</pub-id>
</mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chai</surname> <given-names>Q.</given-names></name>
<name><surname>Wang</surname> <given-names>X.</given-names></name>
<name><surname>Qiang</surname> <given-names>L.</given-names></name>
<name><surname>Zhang</surname> <given-names>Y.</given-names></name>
<name><surname>Ge</surname> <given-names>P.</given-names></name>
<name><surname>Lu</surname> <given-names>Z.</given-names></name>
<etal/>
</person-group>. (<year>2019</year>). 
<article-title>A Mycobacterium tuberculosis surface protein recruits ubiquitin to trigger host xenophagy</article-title>. <source>Nat. Commun.</source> <volume>10</volume>, <fpage>1973</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-019-09955-8</pub-id>, PMID: <pub-id pub-id-type="pmid">31036822</pub-id>
</mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname> <given-names>D. Y.</given-names></name>
<name><surname>Chen</surname> <given-names>Y. M.</given-names></name>
<name><surname>Lin</surname> <given-names>C. F.</given-names></name>
<name><surname>Lo</surname> <given-names>C. M.</given-names></name>
<name><surname>Liu</surname> <given-names>H. J.</given-names></name>
<name><surname>Liao</surname> <given-names>T. L.</given-names></name>
</person-group> (<year>2020</year>). 
<article-title>MicroRNA-889 inhibits autophagy to maintain mycobacterial survival in patients with latent tuberculosis infection by targeting TWEAK</article-title>. <source>mBio</source> <volume>11</volume>, <fpage>e03045</fpage>&#x2013;<lpage>e03019</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mBio.03045-19</pub-id>, PMID: <pub-id pub-id-type="pmid">31992621</pub-id>
</mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname> <given-names>Y. C.</given-names></name>
<name><surname>Fang</surname> <given-names>Y. T.</given-names></name>
<name><surname>Wu</surname> <given-names>C. C.</given-names></name>
<name><surname>Chao</surname> <given-names>T. Y.</given-names></name>
<name><surname>Wang</surname> <given-names>Y. H.</given-names></name>
<name><surname>Tseng</surname> <given-names>C. C.</given-names></name>
<etal/>
</person-group>. (<year>2025</year>). 
<article-title>Increased autophagy activity regulated by LC3B gene promoter DNA methylation is associated with progression to active pulmonary tuberculosis disease</article-title>. <source>Respir. Res.</source> <volume>26</volume>, <elocation-id>86</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12931-025-03149-1</pub-id>, PMID: <pub-id pub-id-type="pmid">40045290</pub-id>
</mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname> <given-names>L.</given-names></name>
<name><surname>Hua</surname> <given-names>J.</given-names></name>
<name><surname>He</surname> <given-names>X.</given-names></name>
</person-group> (<year>2022</year>). 
<article-title>Coexpression network analysis-based identification of critical genes differentiating between latent and active tuberculosis</article-title>. <source>Dis. Markers</source> <volume>2022</volume>, <elocation-id>2090560</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2022/2090560</pub-id>, PMID: <pub-id pub-id-type="pmid">36411825</pub-id>
</mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Clifford</surname> <given-names>V.</given-names></name>
<name><surname>Tebruegge</surname> <given-names>M.</given-names></name>
<name><surname>Zufferey</surname> <given-names>C.</given-names></name>
<name><surname>Germano</surname> <given-names>S.</given-names></name>
<name><surname>Forbes</surname> <given-names>B.</given-names></name>
<name><surname>Cosentino</surname> <given-names>L.</given-names></name>
<etal/>
</person-group>. (<year>2019</year>). 
<article-title>Cytokine biomarkers for the diagnosis of tuberculosis infection and disease in adults in a low prevalence setting</article-title>. <source>Tuberculosis (Edinburgh Scotland)</source> <volume>114</volume>, <fpage>91</fpage>&#x2013;<lpage>102</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tube.2018.08.011</pub-id>, PMID: <pub-id pub-id-type="pmid">30711163</pub-id>
</mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Cubillos-Angulo</surname> <given-names>J. M.</given-names></name>
<name><surname>Arriaga</surname> <given-names>M. B.</given-names></name>
<name><surname>Silva</surname> <given-names>E. C.</given-names></name>
<name><surname>M&#xfc;ller</surname> <given-names>B. L. A.</given-names></name>
<name><surname>Ramalho</surname> <given-names>D. M. P.</given-names></name>
<name><surname>Fukutani</surname> <given-names>K. F.</given-names></name>
<etal/>
</person-group>. (<year>2019</year>). 
<article-title>Polymorphisms in TLR4 and TNFA and risk of mycobacterium tuberculosis infection and development of active disease in contacts of tuberculosis cases in Brazil: A prospective cohort study</article-title>. <source>Clin. Infect. diseases: an Off. Publ. Infect. Dis. Soc. America</source> <volume>69</volume>, <fpage>1027</fpage>&#x2013;<lpage>1035</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/cid/ciy1001</pub-id>, PMID: <pub-id pub-id-type="pmid">30481307</pub-id>
</mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Cui</surname> <given-names>X.</given-names></name>
<name><surname>Meng</surname> <given-names>H.</given-names></name>
<name><surname>Li</surname> <given-names>M.</given-names></name>
<name><surname>Chen</surname> <given-names>X.</given-names></name>
<name><surname>Yuan</surname> <given-names>D.</given-names></name>
<name><surname>Wu</surname> <given-names>C.</given-names></name>
</person-group> (<year>2024</year>). 
<article-title>Exosomal small RNA sequencing profiles in plasma from subjects with latent <italic>mycobacterium tuberculosis</italic> infection</article-title>. <source>Microorganisms</source> <volume>12</volume>, <elocation-id>1417</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/microorganisms12071417</pub-id>, PMID: <pub-id pub-id-type="pmid">39065185</pub-id>
</mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Deng</surname> <given-names>W.</given-names></name>
<name><surname>Long</surname> <given-names>Q.</given-names></name>
<name><surname>Zeng</surname> <given-names>J.</given-names></name>
<name><surname>Li</surname> <given-names>P.</given-names></name>
<name><surname>Yang</surname> <given-names>W.</given-names></name>
<name><surname>Chen</surname> <given-names>X.</given-names></name>
<etal/>
</person-group>. (<year>2017</year>). 
<article-title>Mycobacterium tuberculosis PE_PGRS41 Enhances the Intracellular Survival of M. smegmatis within Macrophages Via Blocking Innate Immunity and Inhibition of Host Defense</article-title>. <source>Sci. Rep.</source> <volume>7</volume>, <elocation-id>46716</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/srep46716</pub-id>, PMID: <pub-id pub-id-type="pmid">28440335</pub-id>
</mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>de Oliveira Rezende</surname> <given-names>A.</given-names></name>
<name><surname>Sab&#xf3;ia</surname> <given-names>R. S.</given-names></name>
<name><surname>da Costa</surname> <given-names>A. C.</given-names></name>
<name><surname>da Silva Monteiro</surname> <given-names>D. M. P.</given-names></name>
<name><surname>Zagmignan</surname> <given-names>A.</given-names></name>
<name><surname>Santiago</surname> <given-names>L.&#xc2;.M.</given-names></name>
<etal/>
</person-group>. (<year>2022</year>). 
<article-title>Restricted activation of the NF-&#x3ba;B pathway in individuals with latent tuberculosis infection after HIF-1&#x3b1; Blockade</article-title>. <source>Biomedicines</source> <volume>10</volume>, <elocation-id>817</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/biomedicines10040817</pub-id>, PMID: <pub-id pub-id-type="pmid">35453567</pub-id>
</mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ding</surname> <given-names>S.</given-names></name>
<name><surname>Huang</surname> <given-names>C.</given-names></name>
<name><surname>Gao</surname> <given-names>J.</given-names></name>
<name><surname>Bi</surname> <given-names>C.</given-names></name>
<name><surname>Zhou</surname> <given-names>Y.</given-names></name>
<name><surname>Cai</surname> <given-names>Z.</given-names></name>
</person-group> (<year>2025</year>). 
<article-title>Exploring T-cell metabolism in tuberculosis: development of a diagnostic model using metabolic genes</article-title>. <source>Eur. J. Med. Res.</source> <volume>30</volume>, <fpage>483</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s40001-025-02768-0</pub-id>, PMID: <pub-id pub-id-type="pmid">40524207</pub-id>
</mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Esaulova</surname> <given-names>E.</given-names></name>
<name><surname>Das</surname> <given-names>S.</given-names></name>
<name><surname>Singh</surname> <given-names>D. K.</given-names></name>
<name><surname>Chore&#xf1;o-Parra</surname> <given-names>J. A.</given-names></name>
<name><surname>Swain</surname> <given-names>A.</given-names></name>
<name><surname>Arthur</surname> <given-names>L.</given-names></name>
<etal/>
</person-group>. (<year>2021</year>). 
<article-title>The immune landscape in tuberculosis reveals populations linked to disease and latency</article-title>. <source>Cell Host Microbe</source> <volume>29</volume>, <fpage>165</fpage>&#x2013;<lpage>178.e8</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.chom.2020.11.013</pub-id>, PMID: <pub-id pub-id-type="pmid">33340449</pub-id>
</mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Est&#xe9;vez</surname> <given-names>O.</given-names></name>
<name><surname>Anibarro</surname> <given-names>L.</given-names></name>
<name><surname>Garet</surname> <given-names>E.</given-names></name>
<name><surname>Pallares</surname> <given-names>&#xc1;.</given-names></name>
<name><surname>Barcia</surname> <given-names>L.</given-names></name>
<name><surname>Calvi&#xf1;o</surname> <given-names>L.</given-names></name>
<etal/>
</person-group>. (<year>2020</year>). 
<article-title>An RNA-seq based machine learning approach identifies latent tuberculosis patients with an active tuberculosis profile</article-title>. <source>Front. Immunol.</source> <volume>11</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2020.01470</pub-id>, PMID: <pub-id pub-id-type="pmid">32760401</pub-id>
</mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Etna</surname> <given-names>M. P.</given-names></name>
<name><surname>Sinigaglia</surname> <given-names>A.</given-names></name>
<name><surname>Grassi</surname> <given-names>A.</given-names></name>
<name><surname>Giacomini</surname> <given-names>E.</given-names></name>
<name><surname>Romagnoli</surname> <given-names>A.</given-names></name>
<name><surname>Pardini</surname> <given-names>M.</given-names></name>
<etal/>
</person-group>. (<year>2018</year>). 
<article-title>Mycobacterium tuberculosis-induced miR-155 subverts autophagy by targeting ATG3 in human dendritic cells</article-title>. <source>PloS Pathog.</source> <volume>14</volume>, <fpage>e1006790</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1006790</pub-id>, PMID: <pub-id pub-id-type="pmid">29300789</pub-id>
</mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Fraz&#xe3;o</surname> <given-names>J. B.</given-names></name>
<name><surname>Thain</surname> <given-names>A.</given-names></name>
<name><surname>Zhu</surname> <given-names>Z.</given-names></name>
<name><surname>Luengo</surname> <given-names>M.</given-names></name>
<name><surname>Condino-Neto</surname> <given-names>A.</given-names></name>
<name><surname>Newburger</surname> <given-names>P. E.</given-names></name>
</person-group> (<year>2015</year>). 
<article-title>Regulation of CYBB gene expression in human phagocytes by a distant upstream NF-&#x3ba;B binding site</article-title>. <source>J. Cell. Biochem.</source> <volume>116</volume>, <fpage>2008</fpage>&#x2013;<lpage>2017</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/jcb.25155</pub-id>, PMID: <pub-id pub-id-type="pmid">25752509</pub-id>
</mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Furin</surname> <given-names>J.</given-names></name>
<name><surname>Cox</surname> <given-names>H.</given-names></name>
<name><surname>Pai</surname> <given-names>M.</given-names></name>
</person-group> (<year>2019</year>). 
<article-title>Tuberculosis</article-title>. <source>Lancet</source> <volume>393</volume>, <fpage>1642</fpage>&#x2013;<lpage>1656</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0140-6736(19)30308-3</pub-id>, PMID: <pub-id pub-id-type="pmid">30904262</pub-id>
</mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Gao</surname> <given-names>J.</given-names></name>
<name><surname>Song</surname> <given-names>L.</given-names></name>
<name><surname>Li</surname> <given-names>D.</given-names></name>
<name><surname>Peng</surname> <given-names>L.</given-names></name>
<name><surname>Ding</surname> <given-names>H.</given-names></name>
</person-group> (<year>2019</year>). 
<article-title>Clinical value of haptoglobin and soluble CD163 testing for the differential diagnosis of tuberculous and Malignant pleural effusions</article-title>. <source>Medicine</source> <volume>98</volume>, <fpage>e17416</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/MD.0000000000017416</pub-id>, PMID: <pub-id pub-id-type="pmid">31626097</pub-id>
</mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Gao</surname> <given-names>J.</given-names></name>
<name><surname>Wang</surname> <given-names>Q.</given-names></name>
<name><surname>Tang</surname> <given-names>Y. D.</given-names></name>
<name><surname>Zhai</surname> <given-names>J.</given-names></name>
<name><surname>Hu</surname> <given-names>W.</given-names></name>
<name><surname>Zheng</surname> <given-names>C.</given-names></name>
</person-group> (<year>2023</year>). 
<article-title>When ferroptosis meets pathogenic infections</article-title>. <source>Trends Microbiol.</source> <volume>31</volume>, <fpage>468</fpage>&#x2013;<lpage>479</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tim.2022.11.006</pub-id>, PMID: <pub-id pub-id-type="pmid">36496309</pub-id>
</mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ge</surname> <given-names>P.</given-names></name>
<name><surname>Lei</surname> <given-names>Z.</given-names></name>
<name><surname>Yu</surname> <given-names>Y.</given-names></name>
<name><surname>Lu</surname> <given-names>Z.</given-names></name>
<name><surname>Qiang</surname> <given-names>L.</given-names></name>
<name><surname>Chai</surname> <given-names>Q.</given-names></name>
<etal/>
</person-group>. (<year>2022</year>). 
<article-title><italic>M. tuberculosis</italic> PknG manipulates host autophagy flux to promote pathogen intracellular survival</article-title>. <source>Autophagy</source> <volume>18</volume>, <fpage>576</fpage>&#x2013;<lpage>594</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/15548627.2021.1938912</pub-id>, PMID: <pub-id pub-id-type="pmid">34092182</pub-id>
</mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hamilton</surname> <given-names>F.</given-names></name>
<name><surname>Schurz</surname> <given-names>H.</given-names></name>
<name><surname>Yates</surname> <given-names>T. A.</given-names></name>
<name><surname>Gilchrist</surname> <given-names>J. J.</given-names></name>
<name><surname>M&#xf6;ller</surname> <given-names>M.</given-names></name>
<name><surname>Naranbhai</surname> <given-names>V.</given-names></name>
<etal/>
</person-group>. (<year>2025</year>). 
<article-title>Altered IL-6 signalling and risk of tuberculosis: a multi-ancestry mendelian randomisation study</article-title>. <source>Lancet Microbe</source> <volume>6</volume>, <fpage>100922</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S2666-5247(24)00162-9</pub-id>, PMID: <pub-id pub-id-type="pmid">39579785</pub-id>
</mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hong</surname> <given-names>G. H.</given-names></name>
<name><surname>Guan</surname> <given-names>Q.</given-names></name>
<name><surname>Peng</surname> <given-names>H.</given-names></name>
<name><surname>Luo</surname> <given-names>X. H.</given-names></name>
<name><surname>Mao</surname> <given-names>Q.</given-names></name>
</person-group> (<year>2022</year>). 
<article-title>Identification and validation of a T-cell-related MIR600HG/hsa-mir-21-5p competing endogenous RNA network in tuberculosis activation based on integrated bioinformatics approaches</article-title>. <source>Front. Genet.</source> <volume>13</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fgene.2022.979213</pub-id>, PMID: <pub-id pub-id-type="pmid">36204312</pub-id>
</mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Huang</surname> <given-names>Z.</given-names></name>
<name><surname>Yao</surname> <given-names>F.</given-names></name>
<name><surname>Liu</surname> <given-names>J.</given-names></name>
<name><surname>Xu</surname> <given-names>J.</given-names></name>
<name><surname>Guo</surname> <given-names>Y.</given-names></name>
<name><surname>Su</surname> <given-names>R.</given-names></name>
<etal/>
</person-group>. (<year>2020</year>). 
<article-title>Up-regulation of circRNA-0003528 promotes mycobacterium tuberculosis associated macrophage polarization via down-regulating miR-224-5p, miR-324-5p and miR-488-5p and up-regulating CTLA4</article-title>. <source>Aging</source> <volume>12</volume>, <fpage>25658</fpage>&#x2013;<lpage>25672</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.18632/aging.104175</pub-id>, PMID: <pub-id pub-id-type="pmid">33318319</pub-id>
</mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>J</surname> <given-names>A.</given-names></name>
<name><surname>R</surname> <given-names>M.</given-names></name>
<name><surname>Chinnakali</surname> <given-names>P.</given-names></name>
</person-group> (<year>2024</year>). 
<article-title>Isoniazid monoresistant tuberculosis treatment outcomes in Puducherry, South India - A mixed methods study</article-title>. <source>Indian J. Tuberculosis</source> <volume>71</volume>, <fpage>S91</fpage>&#x2013;<lpage>S96</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ijtb.2024.05.013</pub-id>, PMID: <pub-id pub-id-type="pmid">39067963</pub-id>
</mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Janssen</surname> <given-names>S.</given-names></name>
<name><surname>Schutz</surname> <given-names>C.</given-names></name>
<name><surname>Ward</surname> <given-names>A.</given-names></name>
<name><surname>Nemes</surname> <given-names>E.</given-names></name>
<name><surname>Wilkinson</surname> <given-names>K. A.</given-names></name>
<name><surname>Scriven</surname> <given-names>J.</given-names></name>
<etal/>
</person-group>. (<year>2017</year>). 
<article-title>Mortality in severe human immunodeficiency virus-tuberculosis associates with innate immune activation and dysfunction of monocytes</article-title>. <source>Clin. Infect. diseases: an Off. Publ. Infect. Dis. Soc. America</source> <volume>65</volume>, <fpage>73</fpage>&#x2013;<lpage>82</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/cid/cix254</pub-id>, PMID: <pub-id pub-id-type="pmid">28369200</pub-id>
</mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Jiang</surname> <given-names>T. T.</given-names></name>
<name><surname>Shi</surname> <given-names>L. Y.</given-names></name>
<name><surname>Wei</surname> <given-names>L. L.</given-names></name>
<name><surname>Li</surname> <given-names>X.</given-names></name>
<name><surname>Yang</surname> <given-names>S.</given-names></name>
<name><surname>Wang</surname> <given-names>C.</given-names></name>
<etal/>
</person-group>. (<year>2017</year>). 
<article-title>Serum amyloid A, protein Z, and C4b-binding protein &#x3b2; chain as new potential biomarkers for pulmonary tuberculosis</article-title>. <source>PloS One</source> <volume>12</volume>, <fpage>e0173304</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0173304</pub-id>, PMID: <pub-id pub-id-type="pmid">28278182</pub-id>
</mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kamolratanakul</surname> <given-names>S.</given-names></name>
<name><surname>Ariyanon</surname> <given-names>W.</given-names></name>
<name><surname>Udompornpitak</surname> <given-names>K.</given-names></name>
<name><surname>Bhunyakarnjanarat</surname> <given-names>T.</given-names></name>
<name><surname>Leelahavanichkul</surname> <given-names>A.</given-names></name>
<name><surname>Dhitavat</surname> <given-names>J.</given-names></name>
<etal/>
</person-group>. (<year>2024</year>). 
<article-title>Comparison of the Single Cell Immune Landscape between Subjects with High <italic>Mycobacterium tuberculosis</italic> Bacillary Loads during Active Pulmonary Tuberculosis and Household Members with Latent Tuberculosis Infection</article-title>. <source>Cells</source> <volume>13</volume>, <elocation-id>362</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/cells13040362</pub-id>, PMID: <pub-id pub-id-type="pmid">38391975</pub-id>
</mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname> <given-names>J. K.</given-names></name>
<name><surname>Lee</surname> <given-names>H. M.</given-names></name>
<name><surname>Park</surname> <given-names>K. S.</given-names></name>
<name><surname>Shin</surname> <given-names>D. M.</given-names></name>
<name><surname>Kim</surname> <given-names>T. S.</given-names></name>
<name><surname>Kim</surname> <given-names>Y. S.</given-names></name>
<etal/>
</person-group>. (<year>2017</year>). 
<article-title>MIR144* inhibits antimicrobial responses against Mycobacterium tuberculosis in human monocytes and macrophages by targeting the autophagy protein DRAM2</article-title>. <source>Autophagy</source> <volume>13</volume>, <fpage>423</fpage>&#x2013;<lpage>441</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/15548627.2016.1241922</pub-id>, PMID: <pub-id pub-id-type="pmid">27764573</pub-id>
</mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lastrucci</surname> <given-names>C.</given-names></name>
<name><surname>B&#xe9;nard</surname> <given-names>A.</given-names></name>
<name><surname>Balboa</surname> <given-names>L.</given-names></name>
<name><surname>Pingris</surname> <given-names>K.</given-names></name>
<name><surname>Souriant</surname> <given-names>S.</given-names></name>
<name><surname>Poincloux</surname> <given-names>R.</given-names></name>
<etal/>
</person-group>. (<year>2015</year>). 
<article-title>Tuberculosis is associated with expansion of a motile, permissive and immunomodulatory CD16(+) monocyte population via the IL-10/STAT3 axis</article-title>. <source>Cell Res.</source> <volume>25</volume>, <fpage>1333</fpage>&#x2013;<lpage>1351</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/cr.2015.123</pub-id>, PMID: <pub-id pub-id-type="pmid">26482950</pub-id>
</mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Li</surname> <given-names>Y.</given-names></name>
<name><surname>Deng</surname> <given-names>Y.</given-names></name>
<name><surname>He</surname> <given-names>J.</given-names></name>
</person-group> (<year>2021</year>). 
<article-title>Monocyte-related gene biomarkers for latent and active tuberculosis</article-title>. <source>Bioengineered</source> <volume>12</volume>, <fpage>10799</fpage>&#x2013;<lpage>10811</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/21655979.2021.2003931</pub-id>, PMID: <pub-id pub-id-type="pmid">34751089</pub-id>
</mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Li</surname> <given-names>J.</given-names></name>
<name><surname>Feng</surname> <given-names>H.</given-names></name>
<name><surname>Chen</surname> <given-names>D.</given-names></name>
<name><surname>Zhang</surname> <given-names>H.</given-names></name>
<name><surname>Liao</surname> <given-names>Y.</given-names></name>
</person-group> (<year>2025</year>). 
<article-title>Autophagy in mycobacterial infections: molecular mechanisms, host-pathogen interactions, and therapeutic opportunities</article-title>. <source>Front. Cell. infection Microbiol.</source> <volume>15</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2025.1640647</pub-id>, PMID: <pub-id pub-id-type="pmid">40851798</pub-id>
</mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Liang</surname> <given-names>S.</given-names></name>
<name><surname>Wang</surname> <given-names>F.</given-names></name>
<name><surname>Bao</surname> <given-names>C.</given-names></name>
<name><surname>Han</surname> <given-names>J.</given-names></name>
<name><surname>Guo</surname> <given-names>Y.</given-names></name>
<name><surname>Liu</surname> <given-names>F.</given-names></name>
<etal/>
</person-group>. (<year>2020</year>). 
<article-title>BAG2 ameliorates endoplasmic reticulum stress-induced cell apoptosis in <italic>Mycobacterium tuberculosis</italic>-infected macrophages through selective autophagy</article-title>. <source>Autophagy</source> <volume>16</volume>, <fpage>1453</fpage>&#x2013;<lpage>1467</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/15548627.2019.1687214</pub-id>, PMID: <pub-id pub-id-type="pmid">31711362</pub-id>
</mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Liu</surname> <given-names>F.</given-names></name>
<name><surname>Chen</surname> <given-names>J.</given-names></name>
<name><surname>Wang</surname> <given-names>P.</given-names></name>
<name><surname>Li</surname> <given-names>H.</given-names></name>
<name><surname>Zhou</surname> <given-names>Y.</given-names></name>
<name><surname>Liu</surname> <given-names>H.</given-names></name>
<etal/>
</person-group>. (<year>2018</year>). 
<article-title>MicroRNA-27a controls the intracellular survival of Mycobacterium tuberculosis by regulating calcium-associated autophagy</article-title>. <source>Nat. Commun.</source> <volume>9</volume>, <fpage>4295</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-018-06836-4</pub-id>, PMID: <pub-id pub-id-type="pmid">30327467</pub-id>
</mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Liu</surname> <given-names>Y.</given-names></name>
<name><surname>He</surname> <given-names>C.</given-names></name>
<name><surname>Zhao</surname> <given-names>H.</given-names></name>
<name><surname>Zhong</surname> <given-names>W.</given-names></name>
<name><surname>Sun</surname> <given-names>S.</given-names></name>
<name><surname>Li</surname> <given-names>Z.</given-names></name>
<etal/>
</person-group>. (<year>2025</year>). 
<article-title>Association between hematological inflammatory markers and latent TB infection: insights from NHANES 2011&#x2013;2012 and transcriptomic data</article-title>. <source>Front. Cell. infection Microbiol.</source> <volume>15</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2025.1556048</pub-id>, PMID: <pub-id pub-id-type="pmid">40176982</pub-id>
</mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Liu</surname> <given-names>K.</given-names></name>
<name><surname>Hong</surname> <given-names>D.</given-names></name>
<name><surname>Zhang</surname> <given-names>F.</given-names></name>
<name><surname>Li</surname> <given-names>X.</given-names></name>
<name><surname>He</surname> <given-names>M.</given-names></name>
<name><surname>Han</surname> <given-names>X.</given-names></name>
<etal/>
</person-group>. (<year>2021</year>). 
<article-title>MicroRNA-106a inhibits autophagy process and antimicrobial responses by targeting ULK1, ATG7, and ATG16L1 during mycobacterial infection</article-title>. <source>Front. Immunol.</source> <volume>11</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2020.610021</pub-id>, PMID: <pub-id pub-id-type="pmid">33505399</pub-id>
</mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Liu</surname> <given-names>Q.</given-names></name>
<name><surname>Ou</surname> <given-names>Q.</given-names></name>
<name><surname>Chen</surname> <given-names>H.</given-names></name>
<name><surname>Gao</surname> <given-names>Y.</given-names></name>
<name><surname>Liu</surname> <given-names>Y.</given-names></name>
<name><surname>Xu</surname> <given-names>Y.</given-names></name>
<etal/>
</person-group>. (<year>2019</year>). 
<article-title>Differential expression and predictive value of monocyte scavenger receptor CD163 in populations with different tuberculosis infection statuses</article-title>. <source>BMC Infect. Dis.</source> <volume>19</volume>, <fpage>1006</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12879-019-4525-y</pub-id>, PMID: <pub-id pub-id-type="pmid">31779590</pub-id>
</mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lubbers</surname> <given-names>R.</given-names></name>
<name><surname>Sutherland</surname> <given-names>J. S.</given-names></name>
<name><surname>Goletti</surname> <given-names>D.</given-names></name>
<name><surname>de Paus</surname> <given-names>R. A.</given-names></name>
<name><surname>van Moorsel</surname> <given-names>C. H. M.</given-names></name>
<name><surname>Veltkamp</surname> <given-names>M.</given-names></name>
<etal/>
</person-group>. (<year>2018</year>). 
<article-title>Complement component C1q as serum biomarker to detect active tuberculosis</article-title>. <source>Front. Immunol.</source> <volume>9</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2018.02427</pub-id>, PMID: <pub-id pub-id-type="pmid">30405622</pub-id>
</mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lyu</surname> <given-names>L.</given-names></name>
<name><surname>Zhang</surname> <given-names>X.</given-names></name>
<name><surname>Li</surname> <given-names>C.</given-names></name>
<name><surname>Yang</surname> <given-names>T.</given-names></name>
<name><surname>Wang</surname> <given-names>J.</given-names></name>
<name><surname>Pan</surname> <given-names>L.</given-names></name>
<etal/>
</person-group>. (<year>2019</year>). 
<article-title>Small RNA profiles of serum exosomes derived from individuals with latent and active tuberculosis</article-title>. <source>Front. Microbiol.</source> <volume>10</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2019.01174</pub-id>, PMID: <pub-id pub-id-type="pmid">31191492</pub-id>
</mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ma</surname> <given-names>S.</given-names></name>
<name><surname>Peng</surname> <given-names>P.</given-names></name>
<name><surname>Duan</surname> <given-names>Z.</given-names></name>
<name><surname>Fan</surname> <given-names>Y.</given-names></name>
<name><surname>Li</surname> <given-names>X.</given-names></name>
</person-group> (<year>2023</year>). 
<article-title>Predicting the progress of tuberculosis by inflammatory response-related genes based on multiple machine learning comprehensive analysis</article-title>. <source>J. Immunol. Res.</source> <volume>2023</volume>, <elocation-id>7829286</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2023/7829286</pub-id>, PMID: <pub-id pub-id-type="pmid">37228444</pub-id>
</mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ma</surname> <given-names>R.</given-names></name>
<name><surname>Yang</surname> <given-names>W.</given-names></name>
<name><surname>Guo</surname> <given-names>W.</given-names></name>
<name><surname>Zhang</surname> <given-names>H.</given-names></name>
<name><surname>Wang</surname> <given-names>Z.</given-names></name>
<name><surname>Ge</surname> <given-names>Z.</given-names></name>
</person-group> (<year>2025</year>). 
<article-title>Single-cell transcriptome analysis reveals the dysregulated monocyte state associated with tuberculosis progression</article-title>. <source>BMC Infect. Dis.</source> <volume>25</volume>, <fpage>210</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12879-025-10612-3</pub-id>, PMID: <pub-id pub-id-type="pmid">39939918</pub-id>
</mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Mayer-Barber</surname> <given-names>K. D.</given-names></name>
<name><surname>Andrade</surname> <given-names>B. B.</given-names></name>
<name><surname>Oland</surname> <given-names>S. D.</given-names></name>
<name><surname>Amaral</surname> <given-names>E. P.</given-names></name>
<name><surname>Barber</surname> <given-names>D. L.</given-names></name>
<name><surname>Gonzales</surname> <given-names>J.</given-names></name>
<etal/>
</person-group>. (<year>2014</year>). 
<article-title>Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk</article-title>. <source>Nature</source> <volume>511</volume>, <fpage>99</fpage>&#x2013;<lpage>103</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nature13489</pub-id>, PMID: <pub-id pub-id-type="pmid">24990750</pub-id>
</mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>McCaffrey</surname> <given-names>E. F.</given-names></name>
<name><surname>Donato</surname> <given-names>M.</given-names></name>
<name><surname>Keren</surname> <given-names>L.</given-names></name>
<name><surname>Chen</surname> <given-names>Z.</given-names></name>
<name><surname>Delmastro</surname> <given-names>A.</given-names></name>
<name><surname>Fitzpatrick</surname> <given-names>M. B.</given-names></name>
<etal/>
</person-group>. (<year>2022</year>). 
<article-title>The immunoregulatory landscape of human tuberculosis granulomas</article-title>. <source>Nat. Immunol.</source> <volume>23</volume>, <fpage>318</fpage>&#x2013;<lpage>329</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41590-021-01121-x</pub-id>, PMID: <pub-id pub-id-type="pmid">35058616</pub-id>
</mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Meier</surname> <given-names>N. R.</given-names></name>
<name><surname>Jacobsen</surname> <given-names>M.</given-names></name>
<name><surname>Ottenhoff</surname> <given-names>T. H. M.</given-names></name>
<name><surname>Ritz</surname> <given-names>N.</given-names></name>
</person-group> (<year>2018</year>). 
<article-title>A systematic review on novel <italic>mycobacterium tuberculosis</italic> antigens and their discriminatory potential for the diagnosis of latent and active tuberculosis</article-title>. <source>Front. Immunol.</source> <volume>9</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2018.02476</pub-id>, PMID: <pub-id pub-id-type="pmid">30473692</pub-id>
</mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Mensah</surname> <given-names>G. I.</given-names></name>
<name><surname>Addo</surname> <given-names>K. K.</given-names></name>
<name><surname>Tetteh</surname> <given-names>J. A.</given-names></name>
<name><surname>Sowah</surname> <given-names>S.</given-names></name>
<name><surname>Loescher</surname> <given-names>T.</given-names></name>
<name><surname>Geldmacher</surname> <given-names>C.</given-names></name>
<etal/>
</person-group>. (<year>2014</year>). 
<article-title>Cytokine response to selected MTB antigens in Ghanaian TB patients, before and at 2 weeks of anti-TB therapy is characterized by high expression of IFN-&#x3b3; and Granzyme B and inter- individual variation</article-title>. <source>BMC Infect. Dis.</source> <volume>14</volume>, <elocation-id>495</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1471-2334-14-495</pub-id>, PMID: <pub-id pub-id-type="pmid">25209422</pub-id>
</mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Min</surname> <given-names>Z.</given-names></name>
<name><surname>Gao</surname> <given-names>J.</given-names></name>
<name><surname>Yu</surname> <given-names>Y.</given-names></name>
</person-group> (<year>2019</year>). 
<article-title>The roles of mitochondrial SIRT4 in cellular metabolism</article-title>. <source>Front. Endocrinol.</source> <volume>9</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fendo.2018.00783</pub-id>, PMID: <pub-id pub-id-type="pmid">30666234</pub-id>
</mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Nangpal</surname> <given-names>P.</given-names></name>
<name><surname>Nagpal</surname> <given-names>N. L.</given-names></name>
<name><surname>Angrish</surname> <given-names>N.</given-names></name>
<name><surname>Khare</surname> <given-names>G.</given-names></name>
</person-group> (<year>2025</year>). 
<article-title>Model systems to study <italic>Mycobacterium tuberculosis</italic> infections: an overview of scientific potential and impediments</article-title>. <source>Front. Cell. infection Microbiol.</source> <volume>15</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2025.1572547</pub-id>, PMID: <pub-id pub-id-type="pmid">40406522</pub-id>
</mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Naranbhai</surname> <given-names>V.</given-names></name>
<name><surname>Fletcher</surname> <given-names>H. A.</given-names></name>
<name><surname>Tanner</surname> <given-names>R.</given-names></name>
<name><surname>O'Shea</surname> <given-names>M. K.</given-names></name>
<name><surname>McShane</surname> <given-names>H.</given-names></name>
<name><surname>Fairfax</surname> <given-names>B. P.</given-names></name>
<etal/>
</person-group>. (<year>2015</year>). 
<article-title>Distinct transcriptional and anti-mycobacterial profiles of peripheral blood monocytes dependent on the ratio of monocytes: lymphocytes</article-title>. <source>EBioMedicine</source> <volume>2</volume>, <fpage>1619</fpage>&#x2013;<lpage>1626</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ebiom.2015.09.027</pub-id>, PMID: <pub-id pub-id-type="pmid">26870787</pub-id>
</mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Noreng</surname> <given-names>S.</given-names></name>
<name><surname>Ota</surname> <given-names>N.</given-names></name>
<name><surname>Sun</surname> <given-names>Y.</given-names></name>
<name><surname>Ho</surname> <given-names>H.</given-names></name>
<name><surname>Johnson</surname> <given-names>M.</given-names></name>
<name><surname>Arthur</surname> <given-names>C. P.</given-names></name>
<etal/>
</person-group>. (<year>2022</year>). 
<article-title>Structure of the core human NADPH oxidase NOX2</article-title>. <source>Nat. Commun.</source> <volume>13</volume>, <fpage>6079</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-022-33711-0</pub-id>, PMID: <pub-id pub-id-type="pmid">36241643</pub-id>
</mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Penn-Nicholson</surname> <given-names>A.</given-names></name>
<name><surname>Mbandi</surname> <given-names>S. K.</given-names></name>
<name><surname>Thompson</surname> <given-names>E.</given-names></name>
<name><surname>Mendelsohn</surname> <given-names>S. C.</given-names></name>
<name><surname>Suliman</surname> <given-names>S.</given-names></name>
<name><surname>Chegou</surname> <given-names>N. N.</given-names></name>
<etal/>
</person-group>. (<year>2020</year>). 
<article-title>RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response</article-title>. <source>Sci. Rep.</source> <volume>10</volume>, <fpage>8629</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-020-65043-8</pub-id>, PMID: <pub-id pub-id-type="pmid">32451443</pub-id>
</mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Petrilli</surname> <given-names>J. D.</given-names></name>
<name><surname>Ara&#xfa;jo</surname> <given-names>L. E.</given-names></name>
<name><surname>da Silva</surname> <given-names>L. S.</given-names></name>
<name><surname>Laus</surname> <given-names>A. C.</given-names></name>
<name><surname>M&#xfc;ller</surname> <given-names>I.</given-names></name>
<name><surname>Reis</surname> <given-names>R. M.</given-names></name>
<etal/>
</person-group>. (<year>2020</year>). 
<article-title>Whole blood mRNA expression-based targets to discriminate active tuberculosis from latent infection and other pulmonary diseases</article-title>. <source>Sci. Rep.</source> <volume>10</volume>, <fpage>22072</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-020-78793-2</pub-id>, PMID: <pub-id pub-id-type="pmid">33328540</pub-id>
</mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Qu</surname> <given-names>Y.</given-names></name>
<name><surname>Gao</surname> <given-names>Q.</given-names></name>
<name><surname>Wu</surname> <given-names>S.</given-names></name>
<name><surname>Xu</surname> <given-names>T.</given-names></name>
<name><surname>Jiang</surname> <given-names>D.</given-names></name>
<name><surname>Xu</surname> <given-names>G.</given-names></name>
</person-group> (<year>2021</year>). 
<article-title>MicroRNA-142-3p inhibits autophagy and promotes intracellular survival of Mycobacterium tuberculosis by targeting ATG16L1 and ATG4c</article-title>. <source>Int. Immunopharmacol.</source> <volume>101</volume>, <elocation-id>108202</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.intimp.2021.108202</pub-id>, PMID: <pub-id pub-id-type="pmid">34619495</pub-id>
</mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ramatchandirin</surname> <given-names>B.</given-names></name>
<name><surname>Sadasivam</surname> <given-names>M.</given-names></name>
<name><surname>Kannan</surname> <given-names>A.</given-names></name>
<name><surname>Prahalathan</surname> <given-names>C.</given-names></name>
</person-group> (<year>2016</year>). 
<article-title>Sirtuin 4 regulates lipopolysaccharide mediated leydig cell dysfunction</article-title>. <source>J. Cell. Biochem.</source> <volume>117</volume>, <fpage>904</fpage>&#x2013;<lpage>916</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/jcb.25374</pub-id>, PMID: <pub-id pub-id-type="pmid">26365714</pub-id>
</mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ren</surname> <given-names>B.</given-names></name>
<name><surname>Jia</surname> <given-names>F.</given-names></name>
<name><surname>Fang</surname> <given-names>Q.</given-names></name>
<name><surname>Xu</surname> <given-names>J.</given-names></name>
<name><surname>Lin</surname> <given-names>K.</given-names></name>
<name><surname>Huang</surname> <given-names>R.</given-names></name>
<etal/>
</person-group>. (<year>2025</year>). 
<article-title>Development of a four autophagy-related gene signature for active tuberculosis diagnosis</article-title>. <source>Front. Cell. infection Microbiol.</source> <volume>15</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2025.1600348</pub-id>, PMID: <pub-id pub-id-type="pmid">40487315</pub-id>
</mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Roe</surname> <given-names>J.</given-names></name>
<name><surname>Venturini</surname> <given-names>C.</given-names></name>
<name><surname>Gupta</surname> <given-names>R. K.</given-names></name>
<name><surname>Gurry</surname> <given-names>C.</given-names></name>
<name><surname>Chain</surname> <given-names>B. M.</given-names></name>
<name><surname>Sun</surname> <given-names>Y.</given-names></name>
<etal/>
</person-group>. (<year>2020</year>). 
<article-title>Blood transcriptomic stratification of short-term risk in contacts of tuberculosis</article-title>. <source>Clin. Infect. diseases: an Off. Publ. Infect. Dis. Soc. America</source> <volume>70</volume>, <fpage>731</fpage>&#x2013;<lpage>737</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/cid/ciz252</pub-id>, PMID: <pub-id pub-id-type="pmid">30919880</pub-id>
</mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ruibal</surname> <given-names>P.</given-names></name>
<name><surname>Voogd</surname> <given-names>L.</given-names></name>
<name><surname>Joosten</surname> <given-names>S. A.</given-names></name>
<name><surname>Ottenhoff</surname> <given-names>T. H. M.</given-names></name>
</person-group> (<year>2021</year>). 
<article-title>The role of donor-unrestricted T-cells, innate lymphoid cells, and NK cells in anti-mycobacterial immunity</article-title>. <source>Immunol. Rev.</source> <volume>301</volume>, <fpage>30</fpage>&#x2013;<lpage>47</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/imr.12948</pub-id>, PMID: <pub-id pub-id-type="pmid">33529407</pub-id>
</mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Saini</surname> <given-names>N. K.</given-names></name>
<name><surname>Baena</surname> <given-names>A.</given-names></name>
<name><surname>Ng</surname> <given-names>T. W.</given-names></name>
<name><surname>Venkataswamy</surname> <given-names>M. M.</given-names></name>
<name><surname>Kennedy</surname> <given-names>S. C.</given-names></name>
<name><surname>Kunnath-Velayudhan</surname> <given-names>S.</given-names></name>
<etal/>
</person-group>. (<year>2016</year>). 
<article-title>Suppression of autophagy and antigen presentation by Mycobacterium tuberculosis PE_PGRS47</article-title>. <source>Nat. Microbiol.</source> <volume>1</volume>, <fpage>16133</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nmicrobiol.2016.133</pub-id>, PMID: <pub-id pub-id-type="pmid">27562263</pub-id>
</mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Sambarey</surname> <given-names>A.</given-names></name>
<name><surname>Devaprasad</surname> <given-names>A.</given-names></name>
<name><surname>Mohan</surname> <given-names>A.</given-names></name>
<name><surname>Ahmed</surname> <given-names>A.</given-names></name>
<name><surname>Nayak</surname> <given-names>S.</given-names></name>
<name><surname>Swaminathan</surname> <given-names>S.</given-names></name>
<etal/>
</person-group>. (<year>2017</year>). 
<article-title>Unbiased identification of blood-based biomarkers for pulmonary tuberculosis by modeling and mining molecular interaction networks</article-title>. <source>EBioMedicine</source> <volume>15</volume>, <fpage>112</fpage>&#x2013;<lpage>126</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ebiom.2016.12.009</pub-id>, PMID: <pub-id pub-id-type="pmid">28065665</pub-id>
</mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Scriba</surname> <given-names>T. J.</given-names></name>
<name><surname>Penn-Nicholson</surname> <given-names>A.</given-names></name>
<name><surname>Shankar</surname> <given-names>S.</given-names></name>
<name><surname>Hraha</surname> <given-names>T.</given-names></name>
<name><surname>Thompson</surname> <given-names>E. G.</given-names></name>
<name><surname>Sterling</surname> <given-names>D.</given-names></name>
<etal/>
</person-group>. (<year>2017</year>). 
<article-title>Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease</article-title>. <source>PloS Pathog.</source> <volume>13</volume>, <fpage>e1006687</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1006687</pub-id>, PMID: <pub-id pub-id-type="pmid">29145483</pub-id>
</mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Sengupta</surname> <given-names>S.</given-names></name>
<name><surname>Nayak</surname> <given-names>B.</given-names></name>
<name><surname>Meuli</surname> <given-names>M.</given-names></name>
<name><surname>Sander</surname> <given-names>P.</given-names></name>
<name><surname>Mishra</surname> <given-names>S.</given-names></name>
<name><surname>Sonawane</surname> <given-names>A.</given-names></name>
</person-group> (<year>2021</year>). 
<article-title><italic>Mycobacterium tuberculosis</italic> phosphoribosyltransferase promotes bacterial survival in macrophages by inducing histone hypermethylation in autophagy-related genes</article-title>. <source>Front. Cell. infection Microbiol.</source> <volume>11</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2021.676456</pub-id>, PMID: <pub-id pub-id-type="pmid">34381738</pub-id>
</mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Shahzad</surname> <given-names>F.</given-names></name>
<name><surname>Bashir</surname> <given-names>N.</given-names></name>
<name><surname>Ali</surname> <given-names>A.</given-names></name>
<name><surname>Nadeem</surname> <given-names>A.</given-names></name>
<name><surname>Ammar</surname> <given-names>A.</given-names></name>
<name><surname>Kashif</surname> <given-names>M.</given-names></name>
<etal/>
</person-group>. (<year>2022</year>). 
<article-title>SLC11A1 genetic variation and low expression may cause immune response impairment in TB patients</article-title>. <source>Genes Immun.</source> <volume>23</volume>, <fpage>85</fpage>&#x2013;<lpage>92</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41435-022-00165-9</pub-id>, PMID: <pub-id pub-id-type="pmid">35140349</pub-id>
</mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Shariq</surname> <given-names>M.</given-names></name>
<name><surname>Quadir</surname> <given-names>N.</given-names></name>
<name><surname>Sharma</surname> <given-names>N.</given-names></name>
<name><surname>Singh</surname> <given-names>J.</given-names></name>
<name><surname>Sheikh</surname> <given-names>J. A.</given-names></name>
<name><surname>Khubaib</surname> <given-names>M.</given-names></name>
<etal/>
</person-group>. (<year>2021</year>). 
<article-title><italic>Mycobacterium tuberculosis</italic> ripA dampens TLR4-mediated host protective response using a multi-pronged approach involving autophagy, apoptosis, metabolic repurposing, and immune modulation</article-title>. <source>Front. Immunol.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2021.636644</pub-id>, PMID: <pub-id pub-id-type="pmid">33746976</pub-id>
</mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Shekarkar Azgomi</surname> <given-names>M.</given-names></name>
<name><surname>Badami</surname> <given-names>G. D.</given-names></name>
<name><surname>Di Caro</surname> <given-names>M.</given-names></name>
<name><surname>Tamburini</surname> <given-names>B.</given-names></name>
<name><surname>Fallo</surname> <given-names>M.</given-names></name>
<name><surname>Dieli</surname> <given-names>C.</given-names></name>
<etal/>
</person-group>. (<year>2024</year>). 
<article-title>Deep immunoprofiling of large-scale tuberculosis dataset at single cell resolution reveals a CD81bright &#x3b3;&#x3b4; T cell population associated with latency</article-title>. <source>Cells</source> <volume>13</volume>, <elocation-id>1529</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/cells13181529</pub-id>, PMID: <pub-id pub-id-type="pmid">39329713</pub-id>
</mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Silva</surname> <given-names>C. A.</given-names></name>
<name><surname>Ribeiro-Dos-Santos</surname> <given-names>A.</given-names></name>
<name><surname>Gon&#xe7;alves</surname> <given-names>W. G.</given-names></name>
<name><surname>Pinto</surname> <given-names>P.</given-names></name>
<name><surname>Pantoja</surname> <given-names>R. P.</given-names></name>
<name><surname>Vinasco-Sandoval</surname> <given-names>T.</given-names></name>
<etal/>
</person-group>. (<year>2021</year>). 
<article-title>Can miRNA Indicate Risk of Illness after Continuous Exposure to <italic>M. tuberculosis</italic></article-title>? <source>Int. J. Mol. Sci.</source> <volume>22</volume>, <elocation-id>3674</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms22073674</pub-id>, PMID: <pub-id pub-id-type="pmid">33916069</pub-id>
</mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Silva</surname> <given-names>D. A. A. D.</given-names></name>
<name><surname>Silva</surname> <given-names>M. V. D.</given-names></name>
<name><surname>Barros</surname> <given-names>C. C. O.</given-names></name>
<name><surname>Alexandre</surname> <given-names>P. B. D.</given-names></name>
<name><surname>Tim&#xf3;teo</surname> <given-names>R. P.</given-names></name>
<name><surname>Catarino</surname> <given-names>J. S.</given-names></name>
<etal/>
</person-group>. (<year>2018</year>). 
<article-title>TNF-&#x3b1; blockade impairs <italic>in vitro</italic> tuberculous granuloma formation and down modulate Th1, Th17 and Treg cytokines</article-title>. <source>PloS One</source> <volume>13</volume>, <fpage>e0194430</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0194430</pub-id>, PMID: <pub-id pub-id-type="pmid">29543912</pub-id>
</mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Singhania</surname> <given-names>A.</given-names></name>
<name><surname>Verma</surname> <given-names>R.</given-names></name>
<name><surname>Graham</surname> <given-names>C. M.</given-names></name>
<name><surname>Lee</surname> <given-names>J.</given-names></name>
<name><surname>Tran</surname> <given-names>T.</given-names></name>
<name><surname>Richardson</surname> <given-names>M.</given-names></name>
<etal/>
</person-group>. (<year>2018</year>). 
<article-title>A modular transcriptional signature identifies phenotypic heterogeneity of human tuberculosis infection</article-title>. <source>Nat. Commun.</source> <volume>9</volume>, <fpage>2308</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-018-04579-w</pub-id>, PMID: <pub-id pub-id-type="pmid">29921861</pub-id>
</mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Strong</surname> <given-names>E. J.</given-names></name>
<name><surname>Jurcic Smith</surname> <given-names>K. L.</given-names></name>
<name><surname>Saini</surname> <given-names>N. K.</given-names></name>
<name><surname>Ng</surname> <given-names>T. W.</given-names></name>
<name><surname>Porcelli</surname> <given-names>S. A.</given-names></name>
<name><surname>Lee</surname> <given-names>S.</given-names></name>
</person-group> (<year>2020</year>). 
<article-title>Identification of autophagy-inhibiting factors of mycobacterium tuberculosis by high-throughput loss-of-function screening</article-title>. <source>Infection Immun.</source> <volume>88</volume>, <fpage>e00269</fpage>&#x2013;<lpage>e00220</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.00269-20</pub-id>, PMID: <pub-id pub-id-type="pmid">32989037</pub-id>
</mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Strong</surname> <given-names>E. J.</given-names></name>
<name><surname>Ng</surname> <given-names>T. W.</given-names></name>
<name><surname>Porcelli</surname> <given-names>S. A.</given-names></name>
<name><surname>Lee</surname> <given-names>S.</given-names></name>
</person-group> (<year>2021</year>). 
<article-title>Mycobacterium tuberculosis PE_PGRS20 and PE_PGRS47 proteins inhibit autophagy by interaction with rab1A</article-title>. <source>mSphere</source> <volume>6</volume>, <fpage>e0054921</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mSphere.00549-21</pub-id>, PMID: <pub-id pub-id-type="pmid">34346699</pub-id>
</mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Su</surname> <given-names>H.</given-names></name>
<name><surname>Zhu</surname> <given-names>S.</given-names></name>
<name><surname>Zhu</surname> <given-names>L.</given-names></name>
<name><surname>Kong</surname> <given-names>C.</given-names></name>
<name><surname>Huang</surname> <given-names>Q.</given-names></name>
<name><surname>Zhang</surname> <given-names>Z.</given-names></name>
<etal/>
</person-group>. (<year>2017</year>). 
<article-title><italic>Mycobacterium tuberculosis</italic> Latent Antigen Rv2029c from the Multistage DNA Vaccine A39 Drives TH1 Responses via TLR-mediated Macrophage Activation</article-title>. <source>Front. Microbiol.</source> <volume>8</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2017.02266</pub-id>, PMID: <pub-id pub-id-type="pmid">29204139</pub-id>
</mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Sweeney</surname> <given-names>T. E.</given-names></name>
<name><surname>Braviak</surname> <given-names>L.</given-names></name>
<name><surname>Tato</surname> <given-names>C. M.</given-names></name>
<name><surname>Khatri</surname> <given-names>P.</given-names></name>
</person-group> (<year>2016</year>). 
<article-title>Genome-wide expression for diagnosis of pulmonary tuberculosis: a multicohort analysis</article-title>. <source>Lancet Respir. Med.</source> <volume>4</volume>, <fpage>213</fpage>&#x2013;<lpage>224</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S2213-2600(16)00048-5</pub-id>, PMID: <pub-id pub-id-type="pmid">26907218</pub-id>
</mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Teh</surname> <given-names>C. E.</given-names></name>
<name><surname>Preston</surname> <given-names>S. P.</given-names></name>
<name><surname>Robbins</surname> <given-names>A. K.</given-names></name>
<name><surname>Stutz</surname> <given-names>M. D.</given-names></name>
<name><surname>Cooney</surname> <given-names>J.</given-names></name>
<name><surname>Clark</surname> <given-names>M. P.</given-names></name>
<etal/>
</person-group>. (<year>2022</year>). 
<article-title>Caspase-8 has dual roles in regulatory T cell homeostasis balancing immunity to infection and collateral inflammatory damage</article-title>. <source>Sci. Immunol.</source> <volume>7</volume>, <fpage>eabn8041</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/sciimmunol.abn8041</pub-id>, PMID: <pub-id pub-id-type="pmid">35333545</pub-id>
</mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Venkatasubramanian</surname> <given-names>S.</given-names></name>
<name><surname>Cheekatla</surname> <given-names>S.</given-names></name>
<name><surname>Paidipally</surname> <given-names>P.</given-names></name>
<name><surname>Tripathi</surname> <given-names>D.</given-names></name>
<name><surname>Welch</surname> <given-names>E.</given-names></name>
<name><surname>Tvinnereim</surname> <given-names>A. R.</given-names></name>
<etal/>
</person-group>. (<year>2017</year>). 
<article-title>IL-21-dependent expansion of memory-like NK cells enhances protective immune responses against Mycobacterium tuberculosis</article-title>. <source>Mucosal Immunol.</source> <volume>10</volume>, <fpage>1031</fpage>&#x2013;<lpage>1042</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/mi.2016.105</pub-id>, PMID: <pub-id pub-id-type="pmid">27924822</pub-id>
</mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname> <given-names>S.</given-names></name>
<name><surname>He</surname> <given-names>L.</given-names></name>
<name><surname>Wu</surname> <given-names>J.</given-names></name>
<name><surname>Zhou</surname> <given-names>Z.</given-names></name>
<name><surname>Gao</surname> <given-names>Y.</given-names></name>
<name><surname>Chen</surname> <given-names>J.</given-names></name>
<etal/>
</person-group>. (<year>2019</year>). 
<article-title>Transcriptional profiling of human peripheral blood mononuclear cells identifies diagnostic biomarkers that distinguish active and latent tuberculosis</article-title>. <source>Front. Immunol.</source> <volume>10</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2019.02948</pub-id>, PMID: <pub-id pub-id-type="pmid">31921195</pub-id>
</mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Warsinske</surname> <given-names>H. C.</given-names></name>
<name><surname>Rao</surname> <given-names>A. M.</given-names></name>
<name><surname>Moreira</surname> <given-names>F. M. F.</given-names></name>
<name><surname>Santos</surname> <given-names>P. C. P.</given-names></name>
<name><surname>Liu</surname> <given-names>A. B.</given-names></name>
<name><surname>Scott</surname> <given-names>M.</given-names></name>
<etal/>
</person-group>. (<year>2018</year>). 
<article-title>Assessment of validity of a blood-based 3-gene signature score for progression and diagnosis of tuberculosis, disease severity, and treatment response</article-title>. <source>JAMA network Open</source> <volume>1</volume>, <fpage>e183779</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1001/jamanetworkopen.2018.3779</pub-id>, PMID: <pub-id pub-id-type="pmid">30646264</pub-id>
</mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wawrocki</surname> <given-names>S.</given-names></name>
<name><surname>Kielnierowski</surname> <given-names>G.</given-names></name>
<name><surname>Rudnicka</surname> <given-names>W.</given-names></name>
<name><surname>Seweryn</surname> <given-names>M.</given-names></name>
<name><surname>Druszczynska</surname> <given-names>M.</given-names></name>
</person-group> (<year>2020</year>). 
<article-title>Interleukin-18, functional IL-18 receptor and IL-18 binding protein expression in active and latent tuberculosis</article-title>. <source>Pathog. (Basel Switzerland)</source> <volume>9</volume>, <elocation-id>451</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/pathogens9060451</pub-id>, PMID: <pub-id pub-id-type="pmid">32521630</pub-id>
</mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wayengera</surname> <given-names>M.</given-names></name>
<name><surname>Mwebaza</surname> <given-names>I.</given-names></name>
<name><surname>Welishe</surname> <given-names>J.</given-names></name>
<name><surname>Bayiyana</surname> <given-names>A.</given-names></name>
<name><surname>Kateete</surname> <given-names>D. P.</given-names></name>
<name><surname>Wampande</surname> <given-names>E.</given-names></name>
<etal/>
</person-group>. (<year>2017</year>). 
<article-title>Immuno-diagnosis of Mycobacterium tuberculosis in sputum, and reduction of timelines for its positive cultures to within 3 h by pathogen-specific thymidylate kinase expression assays</article-title>. <source>BMC Res. Notes</source> <volume>10</volume>, <fpage>368</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13104-017-2649-y</pub-id>, PMID: <pub-id pub-id-type="pmid">28789704</pub-id>
</mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wei</surname> <given-names>Z.</given-names></name>
<name><surname>Wenhao</surname> <given-names>S.</given-names></name>
<name><surname>Yuanyuan</surname> <given-names>M.</given-names></name>
<name><surname>Yang</surname> <given-names>L.</given-names></name>
<name><surname>Daming</surname> <given-names>Z.</given-names></name>
<name><surname>Jiangchun</surname> <given-names>X.</given-names></name>
<etal/>
</person-group>. (<year>2017</year>). 
<article-title>A single nucleotide polymorphism in the interferon-&#x3b3; gene (<italic>IFNG</italic> + 874 T/A) is associated with susceptibility to tuberculosis</article-title>. <source>Oncotarget</source> <volume>8</volume>, <fpage>50415</fpage>&#x2013;<lpage>50429</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.18632/oncotarget.17304</pub-id>, PMID: <pub-id pub-id-type="pmid">28881572</pub-id>
</mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wu</surname> <given-names>M.</given-names></name>
<name><surname>Liu</surname> <given-names>Z.</given-names></name>
<name><surname>Zhang</surname> <given-names>S.</given-names></name>
</person-group> (<year>2022</year>). 
<article-title>Down-regulation of hsa_circ_0045474 induces macrophage autophagy in tuberculosis via miR-582-5p/TNKS2 axis</article-title>. <source>Innate Immun.</source> <volume>28</volume>, <fpage>11</fpage>&#x2013;<lpage>18</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/17534259211064285</pub-id>, PMID: <pub-id pub-id-type="pmid">34861798</pub-id>
</mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wu</surname> <given-names>J.</given-names></name>
<name><surname>Wang</surname> <given-names>S.</given-names></name>
<name><surname>Lu</surname> <given-names>C.</given-names></name>
<name><surname>Shao</surname> <given-names>L.</given-names></name>
<name><surname>Gao</surname> <given-names>Y.</given-names></name>
<name><surname>Zhou</surname> <given-names>Z.</given-names></name>
<etal/>
</person-group>. (<year>2017</year>). 
<article-title>Multiple cytokine responses in discriminating between active tuberculosis and latent tuberculosis infection</article-title>. <source>Tuberculosis (Edinburgh Scotland)</source> <volume>102</volume>, <fpage>68</fpage>&#x2013;<lpage>75</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tube.2016.06.001</pub-id>, PMID: <pub-id pub-id-type="pmid">28061954</pub-id>
</mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yang</surname> <given-names>Z.</given-names></name>
<name><surname>Li</surname> <given-names>J.</given-names></name>
<name><surname>Shen</surname> <given-names>J.</given-names></name>
<name><surname>Cao</surname> <given-names>H.</given-names></name>
<name><surname>Wang</surname> <given-names>Y.</given-names></name>
<name><surname>Hu</surname> <given-names>S.</given-names></name>
<etal/>
</person-group>. (<year>2025</year>). 
<article-title>Recent progress in tuberculosis diagnosis: insights into blood-based biomarkers and emerging technologies</article-title>. <source>Front. Cell. infection Microbiol.</source> <volume>15</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2025.1567592</pub-id>, PMID: <pub-id pub-id-type="pmid">40406513</pub-id>
</mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Zak</surname> <given-names>D. E.</given-names></name>
<name><surname>Penn-Nicholson</surname> <given-names>A.</given-names></name>
<name><surname>Scriba</surname> <given-names>T. J.</given-names></name>
<name><surname>Thompson</surname> <given-names>E.</given-names></name>
<name><surname>Suliman</surname> <given-names>S.</given-names></name>
<name><surname>Amon</surname> <given-names>L. M.</given-names></name>
<etal/>
</person-group>. (<year>2016</year>). 
<article-title>A blood RNA signature for tuberculosis disease risk: a prospective cohort study</article-title>. <source>Lancet (London England)</source> <volume>387</volume>, <fpage>2312</fpage>&#x2013;<lpage>2322</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0140-6736(15)01316-1</pub-id>, PMID: <pub-id pub-id-type="pmid">27017310</pub-id>
</mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Zhang</surname> <given-names>Y.</given-names></name>
<name><surname>Ye</surname> <given-names>X.</given-names></name>
<name><surname>Xu</surname> <given-names>J.</given-names></name>
<name><surname>He</surname> <given-names>J.</given-names></name>
<name><surname>Lu</surname> <given-names>X.</given-names></name>
</person-group> (<year>2025</year>). 
<article-title>Identification and functional characterization of glycosyltransferase-related biomarkers for tuberculosis diagnosis</article-title>. <source>AMB Express</source> <volume>15</volume>, <elocation-id>56</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13568-025-01870-0</pub-id>, PMID: <pub-id pub-id-type="pmid">40153107</pub-id>
</mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Zhou</surname> <given-names>Y.</given-names></name>
<name><surname>Tan</surname> <given-names>C. Y.</given-names></name>
<name><surname>Mo</surname> <given-names>Z. J.</given-names></name>
<name><surname>Gao</surname> <given-names>Q. L.</given-names></name>
<name><surname>He</surname> <given-names>D.</given-names></name>
<name><surname>Li</surname> <given-names>J.</given-names></name>
<etal/>
</person-group>. (<year>2017</year>). 
<article-title>Polymorphisms in the <italic>SP110</italic> and <italic>TNF-&#x3b1;</italic> Gene and susceptibility to pulmonary and spinal tuberculosis among southern chinese population</article-title>. <source>Dis. Markers</source> <volume>2017</volume>, <elocation-id>4590235</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2017/4590235</pub-id>, PMID: <pub-id pub-id-type="pmid">29430075</pub-id>
</mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Zoller</surname> <given-names>T.</given-names></name>
<name><surname>Mfinanga</surname> <given-names>E. H.</given-names></name>
<name><surname>Zumba</surname> <given-names>T. B.</given-names></name>
<name><surname>Asilia</surname> <given-names>P. J.</given-names></name>
<name><surname>Mutabazi</surname> <given-names>E. M.</given-names></name>
<name><surname>Wimmersberger</surname> <given-names>D.</given-names></name>
<etal/>
</person-group>. (<year>2018</year>). 
<article-title>Chronic airflow obstruction in Tanzania - a cross-sectional study</article-title>. <source>BMC pulmonary Med.</source> <volume>18</volume>, <elocation-id>11</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12890-018-0577-9</pub-id>, PMID: <pub-id pub-id-type="pmid">29351754</pub-id>
</mixed-citation>
</ref>
</ref-list>
<fn-group>
<fn id="n1" fn-type="custom" custom-type="edited-by">
<p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1040794">Cheng Chen</ext-link>, Jiangsu Provincial Center for Disease Control And Prevention, China</p></fn>
<fn id="n2" fn-type="custom" custom-type="reviewed-by">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2934011">Mahalakshmi Vijayaraghavan</ext-link>, Texas Tech University Health Sciences Center El Paso, United States</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3237248">Sima Kazemi</ext-link>, Hamadan University of Medical Sciences, Iran</p></fn>
</fn-group>
</back>
</article>